WO2013001435A1 - Phacosporacea resistant soybean plants - Google Patents
Phacosporacea resistant soybean plants Download PDFInfo
- Publication number
- WO2013001435A1 WO2013001435A1 PCT/IB2012/053193 IB2012053193W WO2013001435A1 WO 2013001435 A1 WO2013001435 A1 WO 2013001435A1 IB 2012053193 W IB2012053193 W IB 2012053193W WO 2013001435 A1 WO2013001435 A1 WO 2013001435A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- nucleic acid
- plant
- plants
- gene
- promoter
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8261—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
- C12N15/8271—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance
- C12N15/8279—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, pathogen resistance, disease resistance
- C12N15/8282—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, pathogen resistance, disease resistance for fungal resistance
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
Definitions
- the present invention relates to a method of increasing resistance against fungal pathogens of the family Phacosporaceae in transgenic plants and/or plant cells.
- the ethylene signaling pathway and /or activity of the ethylene signaling compounds is changed. This is achieved by priming the ethylene signaling pathway in these plants in comparison to wild type plants and/or wild type plant cells.
- the activating or inhibitory function of a particular signaling compound overexpression or knock-down of the cognate gene might be used.
- the invention relates to transgenic plants and/or plant cells having an increased resistance against fungal pathogens of the family Phacosporaceae, for example soybean rust and to recombinant expression vectors comprising a sequence that is identical or homologous to a sequence encoding a functional ethylene signaling compound or fragments thereof.
- the cultivation of agricultural crop plants serves mainly for the production of foodstuffs for humans and animals.
- Monocultures in particular, which are the rule nowadays, are highly susceptible to an epidemic-like spreading of diseases. The result is markedly reduced yields.
- the pathogenic organisms have been controlled mainly by using pesticides.
- the possibility of directly modifying the genetic disposition of a plant or pathogen is also open to man.
- Resistance generally means the ability of a plant to prevent, or at least curtail the infestation and colonization by a harmful pathogen. Different mechanisms can be discerned in the naturally occurring resistance, with which the plants fend off colonization by phytopathogenic organisms. These specific interactions between the pathogen and the host determine the course of infec- tion (Schopfer and Brennicke (1999) Dephysiologie, Springer Verlag, Berlin-Heidelberg, Germany).
- race specific resistance also called host resistance
- a differentiation is made between compatible and incompatible interactions.
- an interaction occurs between a virulent pathogen and a susceptible plant.
- the pathogen survives, and may build up reproduction structures, while the host mostly dies off.
- An incompatible interaction occurs on the other hand when the pathogen infects the plant but is inhibited in its growth before or after weak development of symptoms. In the latter case, the plant is resistant to the respective pathogen (Schopfer and Brennicke, vide supra).
- this type of resistance is specific for a certain strain or pathogen.
- pathogens are plant-species specific. This means that a pathogen can induce a disease in a certain plant species, but not in other plant species (Heath (2002) Can. J. Plant Pathol. 24: 259-264).
- the resistance against a pathogen in certain plant species is called non-host resistance.
- the non-host resistance offers strong, broad, and permanent protection from phytopa- thogens.
- Genes providing non-host resistance provide the opportunity of a strong, broad and permanent protection against certain diseases in non-host plants. In particular such a resistance works for different strains of the pathogen.
- PAMP receptors a class of transmembrane receptor like kinases recognizing conserved pathogen associated molecules (e.g. flagellin or chitin).
- SA phytohormones salicylic acid
- JA jasmonate
- ET ethylene
- Fungi are distributed worldwide. Approximately 100 000 different fungal species are known to date. The rusts are of great importance. They can have a complicated development cycle with up to five different spore stages (spermatium, aecidiospore, uredospore, teleutospore and ba- sidiospore).
- the first phases of the interaction between phytopathogenic fungi and their potential host plants are decisive for the colonization of the plant by the fungus.
- the spores become attached to the surface of the plants, germinate, and the fungus penetrates the plant.
- Fungi may penetrate the plant via existing ports such as stomata, lenticels, hydatodes and wounds, or else they penetrate the plant epidermis directly as the result of the mechanical force and with the aid of cell-wall-digesting enzymes.
- Specific infection structures are developed for penetration of the plant.
- the soybean rust Phakopsora pachyrhizi directly penetrates the plant epidermis.
- the fungus After crossing the epidermal cell, the fungus reaches the intercellular space of the mesophyll, where the fungus starts to spread through the leaves. To acquire nutrients the fungus penetrates mesophyll cells and develops haustoria inside the mesophyl cell. During the penetration process the plasmamembrane of the penetrated mesophyll cell stays intact. Therefore the soybean rust fungus establishes a biotrophic interaction with soybean.
- Soybean rust has become increasingly important in recent times.
- the disease may be caused by the biotrophic rusts Phakopsora pachyrhizi (Sydow) and Phakopsora meibomiae (Arthur). They belong to the class Basidiomycota, order Uredinales, family Phakopsoraceae. Both rusts infect a wide spectrum of leguminosic host plants.
- P. pachyrhizi also referred to as Asian rust, is the more aggressive pathogen on soy (Glycine max), and is therefore, at least currently, of great importance for agriculture.
- P. pachyrhizi can be found in nearly all tropical and subtropical soy growing regions of the world.
- pachyrhizi is capable of infecting 31 species from 17 fami- lies of the Leguminosae under natural conditions and is capable of growing on further 60 species under controlled conditions (Sinclair et al. (eds.), Proceedings of the rust workshop (1995), National SoyaResearch Laboratory, Publication No. 1 (1996); Rytter J.L. et al., Plant Dis. 87, 818 (1984)).
- P. meibomiae has been found in the Caribbean Basin and in Puerto Rico, and has not caused substantial damage as yet.
- P. pachyrhizi can currently be controlled in the field only by means of fungicides. Soy plants with resistance to the entire spectrum of the isolates are not available. When searching for resistant plants, four dominant genes Rpp1 -4, which mediate resistance of soy to P. pachyrhizi, were discovered. The resistance was lost rapidly, as P. pychyrhizi develops new virulent races.
- biotrophic fungal pathogens of the family Phacosporaceae for example soybean rust fungus can be controlled by using the ethylene mediated defense, although prior art teaches, that priming the ethylene mediated defense leads to increased susceptibility to biotrophic fungi (Berrocal-Lobo et al. 2002, Plant Journal 29:23-32).
- the ET pathway either by over-expression of several proteins involved in ethylene signaling or by down- regulation of several proteins involved in suppression of the ET signaling pathway.
- ASR Asian Soybean Rust
- ET signaling pathway itself enhances the resistance against soybean rust.
- Overexpression of several proteins involved in ET signaling pathway increases the resistance of soybean against fungal pathogens of the family Phacosporaceae , for example soybean rust.
- Downregulation of ET signaling pathway antagonisitc proteins like CTR1 and EBF1 also increases the resistance of soybean to fungal pathogens of the family Phacosporaceae for example soybean rust.
- ET signaling pathwayantagonisitc proteins like CTR1 and EBF1 increases the susceptibility of soybean to fungal pathogens of the family Phacosporaceae for example soybean rust.
- ET signaling pathwayantagonisitc proteins like CTR1 and EBF1 increases the susceptibility of soybean to fungal pathogens of the family Phacosporaceae for example soybean rust.
- the object of the present invention is to provide a method of increasing resistance against fungal pathogens of the family Phacosporaceae, preferably against fungal pathogens of the genus Phacospora, most preferably against Phakopsora pachyrhizi (Sydow) and Phakopsora meibomiae (Arthur), also known as soy bean rust in transgenic plants and/or transgenic plant cells by using the ethylene signaling pathway, especially by priming the ethylene signaling pathway.
- the nucleic acids of the invention to be overexpressed in order to prime the ethylene signaling pathway and to achieve increased resistance to fungal pathogens of the family Phacosporaceae for example soybean rust are Pti4, Pti5, ERF1 and/or ERF2 as for example defined by any of SEQ ID NO: 1 , 3, 5 or 7 or any homolog, derivative or orthologue or paralogue thereof.
- the priming of the ethylene signaling pathway may also be achieved by the downregulation of repressors of any of Pti4, Pti5, ERF1 and/or ERF2 such as microRNAs or ta-siRNAs targeting these genes.
- the nucleic acids of the invention to be downregulated in order to prime the ethylene signaling pathway and to achieve increased resistance to fungal pathogens of the family Phacosporaceae for example soybean rust are CTR1 , EBF1 and/or EBF2 as for example defined by any of SEQ ID NO: 9, 1 1 , 13, 15, 17, 19, 21 or 23 or any fragment, homolog, derivative or orthologue or paralogue thereof.
- the priming of the ethylene signaling pathway may also be achieved by the overexpression of repressors of any of CTR1 , EBF1 and/or EBF2 such as microRNAs or ta- siRNAs targeting these genes.
- a further object is to provide transgenic plants resistant against fungal pathogens of the family Phacosporaceae, preferably against fungal pathogens of the genus Phacospora, most prefera- bly against Phakopsora pachyrhizi (Sydow) and Phakopsora meibomiae (Arthur), also known as soybean rust, a method for producing such plants as well as a vector construct useful for the above methods.
- This object is achieved by the subject-matter of the main claims.
- Preferred embodiments of the invention are defined by the features of the sub-claims. Definitions:
- priming is to be understood as sensitization of a plant or part thereof to future attack by pests or pathogens in order to induce a resistance against such pests or pathogens.
- the resistance induced by priming is not based on a direct activation of a defense mechanism, but on a sensitization of the plant or tissue of the plant that results in a faster and stronger expres- sion of defense mechanisms compared to an unprimed plant once the plant is exposed to pathogen attack.
- Primer refers herein to the sensitization of a plant or part of a plant so that is able to activate defense mechanisms faster and/or stronger when exposed to one or more biotic stresses compared to a non-primed control plant or part thereof which must rely on a direct de- fense response. Without limiting the scope of the invention, it is believed that priming results in an increased level of signaling factors such as transcription factor (TF) proteins or MAP Kinases and the like in the primed plant or plant tissue compared to non-primed plants or plant tissues.
- TF transcription factor
- primordial TF proteins Upon subsequent exposure of the plant or plant tissue to stress such as pest or pathogen at- tack, these inactive TF proteins become active and regulate gene expression of defense genes, such that a faster and/or stronger defense response is mounted by primed plants or tissues compared to unprimed plants or tissues. Priming may for the application at hand additionally be understood as a constitutive activation of the respective defense mechanism.
- the term "priming of the ethylene signaling pathway” means that the effect of priming is achieved by sensitization of the ethylene signaling pathway as shown in Fig. 1 which leads to a faster and stronger defense response of the ethylene dependent defense mechanisms of the plant or plant tissue.
- the sensitization of the ethylene signaling pathway may be achieved by enhancing the expression of Pti4, Pti5, ERF1 and/or ERF2 protein and/or by suppression of expression of CTR1 , EBF1 and/or EBF2 protein.
- Homologues of a protein encompass peptides, oligopeptides, polypeptides, proteins and/or enzymes having amino acid substitutions, deletions and/or insertions relative to the unmodified protein in question and having similar functional activity as the unmodified protein from which they are derived.
- “Homologues” of a nucleic acid encompass nucleotides and/or polynucleotides having nucleic acid substitutions, deletions and/or insertions relative to the unmodified nucleic acid in question, wherein the protein coded by such nucleic acids has similar or higher functional activity as the unmodified protein coded by the unmodified nucleic acid from which they are derived.
- homologues of a nucleic acid encompass substitutions on the basis of the degenerative amino acid code.
- a “deletion” refers to removal of one or more amino acids from a protein or to the removal of one or more nucleic acids from DNA, ssRNA and/or dsRNA.
- an “insertion” refers to one or more amino acid residues or nucleic acid residues being introduced into a predetermined site in a protein or the nucleic acid.
- substitution refers to replacement of amino acids of the protein with other amino acids having similar properties (such as similar hydrophobicity, hydrophilicity, antigenicity, propensity to form or break ohelical structures or beta-sheet structures).
- a substitution refers a replacement of nucleic acid with other nucleic acids, wherein the protein coded by the modified nucleic acid has a similar function.
- homologues of a nucleic acid encompass substitutions on the basis of the degenerative amino acid code.
- Amino acid substitutions are typically of single residues, but may be clustered depending upon functional constraints placed upon the protein and may range from 1 to 10 amino acids; insertions or deletion will usually be of the order of about 1 to 10 amino acid residues.
- the amino acid substitutions are preferably conservative amino acid substitutions. Conservative substitu- tion tables are well known in the art (see for example Creighton (1984) Proteins. W.H. Freeman and Company (Eds) and Table 1 below).
- Amino acid substitutions, deletions and/or insertions may readily be made using peptide synthetic techniques well known in the art, such as solid phase peptide synthesis and the like, or by recombinant DNA manipulation.
- Orthologues and paralogues encompass evolutionary concepts used to describe the ancestral relationships of genes. Paralogues are genes within the same species that have originated through duplication of an ancestral gene; orthologues are genes from different organisms that have originated through speciation, and are also derived from a common ancestral gene.
- domain refers to a set of amino acids conserved at specific positions along an alignment of sequences of evolutionarily related proteins. While amino acids at other positions can vary between homologues, amino acids that are highly conserved at specific positions indicate amino acids that are likely essential in the structure, stability or function of a protein.
- GAP uses the algorithm of Needle- man and Wunsch ((1970) J Mol Biol 48: 443-453) to find the global (i.e. spanning the complete sequences) alignment of two sequences that maximizes the number of matches and minimizes the number of gaps.
- the BLAST algorithm (Altschul et al. (1990) J Mol Biol 215: 403-10) calculates percent sequence identity and performs a statistical analysis of the similarity between the two sequences.
- the software for performing BLAST analysis is publicly available through the National Centre for Biotechnology Information (NCBI).
- Homologues may readily be identified using, for example, the ClustalW multiple sequence alignment algorithm (version 1 .83), with the default pairwise alignment parameters, and a scoring method in percentage. Global percentages of similarity and identity may also be determined using one of the methods available in the MatGAT software package (Campanella et al., BMC Bioinformatics. 2003 Jul 10;4:29. MatGAT: an application that generates similarity/identity matrices using protein or DNA sequences.). Minor manual editing may be performed to optimise alignment between conserved motifs, as would be apparent to a person skilled in the art. Furthermore, instead of using full-length sequences for the identification of homologues, specific domains may also be used.
- sequence identity values may be determined over the entire nucleic acid or amino acid sequence or over selected domains or conserved motif(s), using the programs mentioned above using the default parameters.
- Smith-Waterman algorithm is particularly useful (Smith TF, Waterman MS (1981 ) J. Mol. Biol 147(1 );195-7).
- the terms “soybean rust-resistance”, “resistant to a soybean rust”, “soybean rust-resistant”, “rust-resistance”, “resistant to a rust”, “rust-resistant”, “fungal-resistance”, “resistant to a fungus” and/or “fungal-resistant” mean reducing or preventing an infection by Phaco- sporacea , in particular Phakopsora pachyrhizi (Sydow) and Phakopsora meibomiae (Arthur) also known as soybean rust or Asian Soybean Rust (ASR).
- the term “resistance” refers to soybean resistance. Resistance does not imply that the plant necessarily has 100% resistance to infection.
- the resistance to infection by soy bean rust in a resistant plant is greater than 10%, 20%, 30%, 40%, 50%, 60%, 70%, 80%, 90%, or 95% in comparison to a wild type plant that is not resistant to soybean rust.
- the wild type plant is a plant of a similar, more preferably identical, genotype as the plant having increased resistance to the soybean rust, but does not comprise a recombinant nucleic acid of the invention, functional fragments thereof and/or a nucleic acid capable of hybridizing with a nucleic acid of the invention.
- soybean rust-resistance refers to the ability of a plant, as compared to a wild type plant, to avoid infection by fungal pathogens of the family Phacosporaceae, for example of the genus Phacospora, such as Phakopsora pachyrhizi (Sydow) and Phakopsora meibomiae (Arthur), also known as soybean rust, to kill rust, to hamper, to reduce, to delay, to stop the development, growth and/or multiplication of soybean rust.
- the level of fungal resistance of a plant can be determined in various ways, e.g. by scoring/measuring the infected leaf area in relation to the overall leaf area. Another possibility to determine the level of resistance is to count the number of soybean rust colonies on the plant or to measure the amount of spores produced by these colonies. Another way to resolve the degree of fungal infestation is to specifically measure the amount of rust DNA by quantitative (q) PCR. Specific probes and primer sequences for most fungal pathogens are available in the literature (Frederick RD, Snyder CL, Peterson GL, et al. 2002 Polymerase chain reaction assays for the detection and discrimination of the rust pathogens Phakopsora pachyrhizi and P.
- the soybean rust resistance is nonhost-resistance.
- Nonhost-resistance means that the plants are resistant to at least 80 %, at least 90%, at least 95%, at least 98%, at least 99% and preferably 100% of the strains of the soybean rust pathogen, preferably the strains of Phakopsora pachyrhizi.
- the term "hybridization” as used herein includes "any process by which a strand of nucleic acid molecule joins with a complementary strand through base pairing.” (J. Coombs (1994) Dictionary of Biotechnology, Stockton Press, New York).
- Hybridization and the strength of hybridization is impacted by such factors as the degree of complementarity between the nucleic acid molecules, stringency of the conditions involved, the Tm of the formed hybrid, and the G:C ratio within the nucleic acid molecules.
- Tm is used in reference to the "melting temperature.”
- the melting temperature is the temperature at which a population of double-stranded nucleic acid molecules becomes half dissociated into single strands.
- the equation for calculating the Tm of nucleic acid molecules is well known in the art.
- Tm 81.5+0.41 (% G+C)
- Other references include more sophisticated computations, which take structural as well as sequence characteristics into account for the calculation of Tm. Stringent conditions, are known to those skilled in the art and can be found in Current Protocols in Molecular Biology, John Wiley & Sons, N.Y. (1989), 6.3.1 - 6.3.6.
- stringency conditions refers to conditions, wherein 100 contigous nucleo- tides or more, 150 contigous nucleotides or more, 200 contigous nucleotides or more or 250 contigous nucleotides or more which are a fragment or identical to the complementary nucleic acid molecule (DNA, RNA, ssDNA orssRNA) hybridizes under conditions equivalent to hybridization in 7% sodium dodecyl sulfate (SDS), 0.5 M NaP04, 1 mM EDTA at 50°C with washing in 2 X SSC, 0.1 % SDS at 50°C or 65°C, preferably at 65°C, with a specific nucleic acid molecule (DNA; RNA, ssDNA or ss RNA).
- SDS sodium dodecyl sulfate
- the hybridizing conditions are equivalent to hybridization in 7% sodium dodecyl sulfate (SDS), 0.5 M NaP04, 1 mM EDTA at 50°C with washing in 1 X SSC, 0.1 % SDS at 50°C or 65°C, preferably 65°C, more preferably the hybridizing conditions are equivalent to hybridization in 7% sodium dodecyl sulfate (SDS), 0.5 M NaP04, 1 mM EDTA at 50°C with washing in 0,1 X SSC, 0.1 % SDS at 50°C or 65°C, preferably 65°C.
- the complementary nucleotides hybridize with a fragment or the whole nucleic acids of the invention.
- the complementary polynucleotide hybridizes with parts of the nucleic acids of the invention capable to provide soybean rust resistance by overexpression or down- regulation, respectively.
- nucleic acid of the invention or “amino acid of the invention” refers to a gene having at least 60 % identity with any of SEQ-ID-No. 1 , 3, 5, 7, 9, 1 1 , 13, 15, 17, 19, 21 or 23 or with a sequence coding for a protein having at least 60% identity with SEQ-ID-No. 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22 or 24 and/or functional fragments thereof.
- homologues of the nucleic acids of the invention have, at the DNA level and/or protein level, at least 70%, preferably of at least 80%, especially preferably of at least 90%, quite especially preferably of at least 95%, quite especially preferably of at least 98%, 99% or 100% identity over the entire DNA region or protein region given in a sequence specifically disclosed herein and/or a functional fragment thereof.
- amino acid of the invention refers to a protein having at least 60 % identity to a sequence coding for a protein having SEQ-ID-No. 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22 or 24 and/or a fragment thereof.
- homologues of the amino acids of the invention have at least 70%, preferably of at least 80%, especially preferably of at least 90%, quite especially preferably of at least 95%, quite especially preferably of at least 98%, 99% or 100% identity over the entire protein region given in a sequence specifically disclosed herein and/or a functional fragment thereof.
- identity may be calculated by means of the Vector NTI Suite 7.1 program of the company Informax (USA) employing the Clustal Method (Higgins DG, Sharp PM. Fast and sensitive multiple sequence alignments on a microcomputer. Comput Appl. Biosci. 1989 Apr;
- Gap opening penalty 10 Gap extension penalty 10
- the identity may be determined according to Chenna, Ramu, Sugawara, Hideaki, Koike, Tadashi, Lopez, Rodrigo, Gibson, Toby J, Higgins, Desmond G, Thompson, Julie D. Multiple sequence alignment with the Clustal series of programs. (2003) Nucleic Acids Res 31 (13):3497-500, the web page: http://www.ebi.ac.Uk/Tools/clustalw/index.html# and the following settings
- nucleic acid sequences mentioned herein can be produced in a known way by chemical synthesis from the nucleotide building blocks, e.g. by fragment condensation of individual overlapping, complementary nucleic acid building blocks of the double helix.
- Chemical synthesis of oligonucleotides can, for example, be performed in a known way, by the phos- phoamidite method (Voet, Voet, 2nd edition, Wiley Press, New York, pages 896-897).
- the accumulation of synthetic oligonucleotides and filling of gaps by means of the Klenow fragment of DNA polymerase and ligation reactions as well as general cloning techniques are described in Sambrook et al. (1989), see below.
- Sequence identity between the nucleic acid useful according to the present invention and the nucleic acids of the invention may be optimized by sequence comparison and alignment algorithms known in the art (see Gribskov and Devereux, Sequence Analysis Primer, Stockton Press, 1991 , and references cited therein) and calculating the percent difference between the nucleotide sequences by, for example, the Smith-Waterman algorithm as implemented in the BESTFIT software program using default parameters (e.g., University of Wisconsin Genetic Computing Group). At least 60% sequence identity, preferably at least 70% sequence identity, 80 % 90%, 95 %, 98%, 99% sequence identity, or even 100% sequence identity, with the nucleic acids having any of SEQ-ID-No. 1 , 3, 5, 7, 9, 1 1 , 13, 15, 17, 19, 21 or 23 is preferred.
- plant is intended to encompass plants at any stage of maturity or development, as well as any tissues or organs (plant parts) taken or derived from any such plant unless other- wise clearly indicated by context.
- Plant parts include, but are not limited to, plant cells, stems, roots, flowers, ovules, stamens, seeds, leaves, embryos, meristematic regions, callus tissue, anther cultures, gametophytes, sporophytes, pollen, microspores, protoplasts, hairy root cultures, and/or the like.
- the present invention also includes seeds produced by the plants of the present invention.
- the seeds comprise the recombinant nucleic acids of the inven- tion.
- the seeds are true breeding for an increased resistance to fungal infection as compared to a wild-type variety of the plant seed.
- a "plant cell” includes, but is not limited to, a protoplast, gamete producing cell, and a cell that regenerates into a whole plant. Tissue culture of various tissues of plants and regeneration of plants therefrom is well known in the art and is widely published.
- the plant is selected from the group consisting of beans, soya, pea, clover, kudzu, lucerne, lentils, lupins, vetches, and/or groundnut.
- the plant is a legume, comprising plants of the genus Phaseolus (comprising French bean, dwarf bean, climbing bean (Phaseolus vulgaris), Lima bean (Phaseolus lunatus L), Tepary bean (Phaseolus acutifolius A.
- Glycine comprising Glycine soja, soybeans (Glycine max (L.) Merill)
- pea comprising shelling peas (Pisum sativum L. convar. sativum), also called smooth or round-seeded peas; marrowfat pea (Pisum sativum L. convar. medullare Alef. emend. CO. Lehm), sugar pea (Pisum sativum L. convar. axiphium Alef emend. CO.
- Lehm also called snow pea, edible-podded pea or mangetout, (Pisum granda sneida L. convar. sneidulo p. shneiderium)); peanut (Arachis hypogaea), clover (Trifolium spec), medick (Medicago), kudzu vine (Pueraria lobata), common lucerne, alfalfa (M.
- sativa L. chickpea (Cicer), lentils (Lens) (Lens culinaris Medik.), lupins (Lupinus); vetches (Vicia), field bean, broad bean (Vicia faba), vetchling (Lathyrus) (comprising chickling pea (Lathyrus sativus), heath pea (Lathyrus tuberosus)); genus Vigna (comprising moth bean (Vigna aconitifolia (Jacq.) Marechal), adzuki bean (Vigna angularis (Willd.) Ohwi & H.
- Recombinant nucleic acid of the invention refers to the same gene (or a substantially homologous nucleic acid/gene) in an isolated form subsequently (re)introduced into a plant (a transgene).
- a transgenic plant containing such a transgene may, when compared to the ex- pression of the endogenous gene, encounter a substantial increase of the transgene expression or downregulation of the corresponding endogene respectively.
- the isolated gene may be isolated from an organism or may be manmade, for example by chemical synthesis.
- a transgenic plant according to the present invention includes a recombinant nucleic acid of the invention integrated at any genetic loci and optionally the plant may also include the endogenous gene within the natural genetic background.
- genetic control sequence(s) which is operably linked with the -nucleic acid sequence of the invention according to the invention, for example a promoter, or
- (c) a) and b) are not located in their natural genetic environment or have been modified by man by gentechnological methods.
- the modification may take the form of, for example, a substitution, addition, deletion, inversion or insertion of one or more nucleotide residues.
- the natural genetic environ- ment is understood as meaning the natural genomic or chromosomal locus in the original plant or the presence in a genomic library or the combination with the natural promoter.
- the natural genetic environment of the nucleic acid sequence is preferably retained, at least in part.
- the environment flanks the nucleic acid sequence at least on one side and has a sequence length of at least 50 bp, preferably at least 500 bp, especially preferably at least 1000 bp, most preferably at least 5000 bp.
- a naturally occurring expression cassette for example the naturally occurring combination of the natural promoter of the nucleic acid sequences with the corresponding nucleic acid sequence encoding a protein useful in the methods of the present invention, as defined above - becomes a recombinant expression cassette when this expression cassette is not integrated in the natural genetic environment but in a different genetic environment.
- isolated nucleic acid or isolated protein
- isolated protein may in some instances be considered as a synonym for a "recombinant nucleic acid” or a “recombinant protein”, respectively and refers to a nucleic acid or protein that is not located in its natural genetic environment and/or that has been modified by gentech- nical methods.
- transgenic preferably refers to any plant, plant cell, callus, plant tissue, or plant part that contains the recombinant construct or vector or expression cassette of the invention or a part thereof which is preferably introduced by non-essentially biological processes, preferably Agrobacteria transformation.
- the recombinant construct or a part thereof is stably integrated into a chromosome, so that it is passed on to successive generations by clonal propagation, vegetative propagation or sexual propagation. Said successive generations are also transgenic.
- Essentially biological processes may be crossing of plants and/or natural recombination.
- a transgenic plant, plants cell or tissue for the purposes of the invention is thus understood as meaning that the recombinant construct or vector or expression cassette of the invention is integrated into the genome.
- constructs or vectors or expression cassettes of the invention are not present in the genome of the original plant or are present in the genome of the transgenic plant not at their natural locus of the genome of the original plant.
- Natural locus means the location on a specific chromosome, preferably the location between certain genes, more preferably the same sequence background as in the original plant which is transformed.
- the transgenic plant, plant cell or tissue thereof expresses the constructs or expression cassettes of the invention.
- expression means the transcription of a specific gene or spe- cific genes or specific genetic vector construct.
- expression in particular means the transcription of a gene or genes or genetic vector construct into structural RNA (rRNA, tRNA), a regulatory RNA (e.g. microRNA, siRNA, ta-siRNA) or mRNA with or without subsequent translation of the latter into a protein.
- rRNA structural RNA
- tRNA structural RNA
- regulatory RNA e.g. microRNA, siRNA, ta-siRNA
- mRNA e.g. microRNA, siRNA, ta-siRNA
- increased expression or “enhanced expression” or “overexpression” or “increase of content” as used herein means any form of expression that is additional to the original wild-type expression level.
- the original wild-type expression level might also be zero (absence of expression).
- Isolated nucleic acids which serve as promoter or enhancer elements may be introduced in an appropriate position (typically upstream) of a non- heterologous form of a polynucleotide so as to upregulate expression of a nucleic acid encoding the protein of interest.
- endogenous promoters may be altered in vivo by mutation, deletion, and/or substitution (see, Kmiec, US 5,565,350; Zarling et al., W09322443), or isolated promoters may be introduced into a plant cell in the proper orientation and distance from a gene of the present invention so as to control the expression of the gene.
- polyadenylation region at the 3'-end of a polynucleotide coding region.
- the polyadenylation region can be derived from the natural gene, from a variety of other plant genes, or from T-DNA.
- the 3' end sequence to be added may be derived from, for example, the nopaline synthase or octopine synthase genes, or alternatively from another plant gene, or less preferably from any other eukaryotic gene.
- An intron sequence may also be added to the 5' untranslated region (UTR) and/or the coding sequence of the partial coding sequence to increase the amount of the mature message that accumulates in the cytosol.
- UTR 5' untranslated region
- coding sequence of the partial coding sequence to increase the amount of the mature message that accumulates in the cytosol.
- Inclusion of a spliceable intron in the transcription unit in both plant and animal expression constructs has been shown to increase gene expression at both the mRNA and protein levels up to 1000-fold (Buchman and Berg (1988) Mol. Cell biol. 8: 4395- 4405; Callis et al. (1987) Genes Dev 1 :1 183-1200).
- Such intron enhancement of gene expres- sion is typically greatest when placed near the 5' end of the transcription unit.
- the term "functional fragment” refers to any nucleic acid and/or protein which comprises merely a part of the fulllength nucleic acid and/or fulllength protein but still provides the same function, i.e. soybean rust resistance when expressed or repressed in a plant respectively.
- the fragment comprises at least 50%, at least 60%, at least 70%, at least 80 %, at least 90 % at least 95%, at least 98 %, at least 99% of the original sequence.
- the functional fragment comprises contiguous nucleic acids or amino acids as in the original nucleic acid and/or original protein.
- the fragment of any of the nucleic acids of the invention has an identity as defined above over a length of at least 20%, at least 30%, at least 50%, at least 75%, at least 90% of the nucleotides of the respective nucleic acid of the invention to the respective nucleic acid of the invention.
- similar functional activity means that any homologue and/or fragment provide soybean rust resistance when expressed in a plant.
- similar functional activity means at least 50%, at least 60%, at least 70%, at least 80 %, at least 90 %, at least 95%, at least 98 %, at least 99% or 100% or higher of the soybean rust resistance compared with functional activity provided by the recombinant expression of any of the nucleotide sequences of the invention as defined by SEQ-ID No. 1 , 3, 5, 7, 9, 1 1 , 13, 15, 17, 19, 21 or 23 and/or recombinant protein of the invention as defined by SEQ-ID No. 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22 or 24.
- the term "increased activity” as used herein means any protein having increased activity provides an increased soybean rust resistance compared with the wildtype plant merely expressing the respective endogenous nucleic acid of the invention. As far as overexpression is concerned, for the purposes of this invention, the original wild-type expression level might also be zero (absence of expression).
- Repress or “downregulate” or “suppress” the expression of a nucleic acid molecule in a plant cell are used equivalently herein and mean that the level of expression of the nucleic acid mole- cule or the level of protein activity of the protein encoded by the nucleic acid molecule in a plant, part of a plant or plant cell after applying a method of the present invention is lower than its expression in the plant, part of the plant or plant cell before applying the method, or compared to a reference plant lacking a recombinant nucleic acid molecule of the invention.
- repressed or “downregulated” or “suppressed” as used herein are synonymous and means here- in lower, preferably significantly lower expression of the nucleic acid molecule to be expressed or activity of the protein to be expressed.
- a “repression” or “downregulation” or “suppression” of the level of an agent such as a protein, mRNA or RNA means that the level is reduced relative to a substantially identical plant, part of a plant or plant cell grown under substantially identical conditions, lacking a recombinant nucleic acid molecule of the invention, for example lacking the region complementary to at least a part of the precursor molecule of the srRNA, the recombinant construct or recombinant vector of the invention.
- repression or “downregulation” or “suppression” of the level of an agent means that the amount is reduced 10% or more, for example 20% or more, preferably 30% or more, more preferably 50% or more, even more preferably 70% or more, most preferably 80% or more for example 90% relative to a cell or organism lacking a recombinant nucleic acid molecule of the invention.
- the repression or downregulation can be determined by methods with which the skilled worker is familiar.
- the downregulation, repression or suppression of the nucleic acid or protein or protein activity quantity can be deter- mined for example by an immunological detection of the protein.
- techniques such as protein assay, fluorescence, Northern hybridization, nuclease protection assay, reverse transcription (quantitative RT-PCR), ELISA (enzyme-linked immunosorbent assay), Western blotting, radioimmunoassay (RIA) or other immunoassays and fluorescence-activated cell analysis (FACS) can be employed to measure a specific protein or RNA in a plant or plant cell.
- Depend- ing on the type of the target protein product, its activity or the effect on the phenotype of the organism or the cell may also be determined.
- Methods for determining the protein quantity are known to the skilled worker. Examples, which may be mentioned, are: the micro-Biuret method (Goa J (1953) Scand J Clin Lab Invest 5:218-222), the Folin-Ciocalteau method (Lowry OH et al. (1951 ) J Biol Chem 193:265-275) or measuring the absorption of CBB G-250 (Bradford MM (1976) Analyt Biochem 72:248-254).
- a method for increasing resistance to Phacosporacea, for example soy bean rust wherein the ethylene signaling pathway is primed in comparison to wild-type plants or wild-type plant cells by enhancing the expression of a Pti4, Pti5, ERF1 and/or ERF2 protein or a functional fragment, orthologue, paralogue or homologue thereof is one embodiment of the invention.
- a method for increasing resistance to Phacosporacea, for example soy bean rust wherein the priming of the ethylene signaling pathway may be achieved by enhancing the expression of a Pti4, Pti5, ERF1 and/or ERF2 protein or a functional fragment, orthologue, paralogue or homologue thereof wherein the Pti4, Pti5, ERF1 and/or ERF2 protein is encoded by
- a recombinant nucleic acid having at least 60% identity preferably at least 70% sequence identity, 80 % 90%, 95 %, 98%, 99% sequence identity, or even 100% sequence identity with SEQ ID No. 1 , 3, 5 or 7, a functional fragment thereof and/or a recombinant nucleic acid capable of hybridizing under stringent conditions with such nucleic acids thereof and/or by
- the priming of the ethylene signaling pathway is achieved by a method comprising the steps of
- a recombinant nucleic acid having at least 60% identity preferably at least 70% sequence identity, 80 % 90%, 95 %, 98%, 99% sequence identity, or even 100% sequence identity with SEQ-ID-No. 1 , 3, 5 or 7and/or a functional fragment thereof and/or a recombinant nucleic acid capable of hybridizing under stringent conditions with such nucleic acids thereof and/or
- a recombinant nucleic acid coding for a protein having at least 60% identity preferably at least 70% sequence identity, 80 % 90%, 95 %, 98%, 99% sequence identity, or even 100% sequence identity with SEQ ID No. 2, 4, 6 or 8, a functional fragment thereof, an orthologue and/or a paralogue thereof
- a recombinant vector construct comprising:
- nucleic acid having at least 60% identity preferably at least 70% sequence identity, 80 % 90%, 95 %, 98%, 99% sequence identity, or even 100% sequence iden- tity with SEQ ID No. 1 , 3, 5 or 7, a functional fragment thereof and/or a nucleic acid capable of hybridizing under stringent conditions with such a nucleic acid and/or
- a recombinant nucleic acid coding for a protein having at least 60% identity preferably at least 70% sequence identity, 80 % 90%, 95 %, 98%, 99% sequence identity, or even 100% sequence identity with SEQ ID No. 2, 4, 6 or 8, a functional fragment thereof, an orthologue and/or a paralogue thereof
- a transcription termination sequence is a further embodiment of the invention.
- target nucleic acid preferably refers to a DNA-molecule capable to prevent the expression, reduce the amount and/or function of the plant CTR1 , EBF1 and/or EBF2 gene as for example defined by SEQ ID NO: 9, 1 1 , 13, 15, 17, 19, 21 or 23 in the plant or parts of the plant.
- target gene refers to a gene the expression of which is to be down- regulated or suppressed.
- target genes are preferably plant CTR1 , EBF1 and/or EBF2 gene as for example defined by SEQ ID NO: 9, 1 1 , 13, 15, 17, 19, 21 or 23 or homologues, paralogues or functional equivalents thereof.
- the present invention provides a method for increasing resistance to fungal pathogens of the family Phacosporaceae, preferably against fungal pathogens of the genus Phacospora, most preferably against Phakopsora pachyrhizi (Sydow) and Phakopsora meibomiae (Arthur), also known as soy bean rust in plants and/or plant cells, wherein the ethylene signaling pathway is primed in comparison to wild type plants and/or wild type plant cells by downregulation or suppression of expression of a CTR1 , EBF1 and/or an EBF2 protein.
- the CTR1 , EBF1 and/or EBF2 protein is encoded by (i) a recombinant nucleic acid having at least 60%, preferably at least 70%, for example at least 75%, more preferably at least 80%, for example at least 85%, even more preferably at least 90%, for example at least 95% or at least 96% or at least 97% or at least 98% most preferably 99% identity with SEQ ID No. 9, 1 1 , 13, 15, 17, 19, 21 or 23, a functional fragment thereof and/or a recombinant nucleic acid capable of hybridizing under stringent conditions with such nucleic acids thereof and/or by
- a recombinant nucleic acid encoding a protein having at least 60% identity, preferably at least 70%, for example at least 75%, more preferably at least 80%, for example at least 85%, even more preferably at least 90%, for example at least 95% or at least 96% or at least 97% or at least 98% most preferably 99% homology with SEQ ID No. 10, 12, 14, 16, 18, 20, 22 or 24, a functional fragment thereof, an orthologue and/or a paralogue thereof.
- a method for increasing resistance to fungal pathogens of the family Phacosporaceae, preferably against fungal pathogens of the genus Phacospora, most preferably against Phakopsora pachyrhizi (Sydow) and Phakopsora meibomiae (Arthur), also known as soy bean rust in plants and/or plant cells, wherein the ethylene signaling pathway is primed in comparison to wild type plants and/or wild type plant cells by downregulation or suppression of expression of a CTR1 , EBF1 and/or an EBF2 protein is comprising the steps of
- the recombinant nucleic acid is able to provide dsRNA and/or si-RNA and/or miRNA in the plant, a part thereof, once the recombinant nucleic acid is expressed, wherein at least 19, preferably at least 20, more preferably at least 21 , for example 22 or 23 contiguous nucleotides of the dsRNA and/or siRNA and/or miRNA are substantially complementary to the target CTR1 , EBF1 and/or EBF2 -gene.
- said recombinant nucleic acid comprises a promoter that is functional in the plant cell, operably linked to a target nucleic acid which is substantial identical and/or substantially complementary to at least 19, preferably at least 20, more preferably at least 21 , for example 22 or 23 contiguous nucleotides of the target CTR1 , EBF1 and/or EBF2 -gene and which, when it is transcribed, generates RNA comprising a first strand having a sequence substantially complementary to at least 19 preferably at least 20, more preferably at least 21 , for example 22 or 23 contiguous nucleotides of the target CTR1 , EBF1 and/or EBF2 -gene and a second strand having a sequence substantially complementary to the first strand or parts thereof, and a terminator regulatory sequence.
- said recombinant nucleic acid comprises a promoter that is functional in the plant cell, operably linked to a target nucleic acid which, when it is transcribed, generates RNA comprising a first strand having a sequence substantially identical or substantially complementary to at least contiguous 19 preferably at least 20, more preferably at least 21 , for example 22 or 23 nucleotides of the target CTR1 , EBF1 and/or EBF2 -gene, and a terminator regulatory sequence.
- recombinant vector constructs comprising a recombinant nucleic acid comprising a promoter that is functional in the plant cell, operably linked to a target nucleic acid which is substantially identical and/or substantially complementary to at least 19 preferably at least 20, more preferably at least 21 , for example 22 or 23 contiguous nucleotides of the target CTR1 , EBF1 and/or EBF2 -gene and a terminator regulatory sequence.
- the recombinant vector constructs of the invention as defined above may further comprise a promoter that is functional in the plant cell, operably linked to a target nucleic acid which is substantial identical and/or substantially complementary to at least 19 preferably at least 20, more preferably at least 21 , for example 22 or 23 contiguous nucleotides of the target CTR1 , EBF1 and/or EBF2 -gene and which, when it is transcribed, generates RNA comprising a first strand having a sequence substantially complementary to at least 19 preferably at least 20, more preferably at least 21 , for example 22 or 23 contiguous nucleotides of the target CTR1 , EBF1 and/or EBF2 -gene and optionally a second strand having a sequence at substantially complementary to the first strand or parts thereof, and a terminator regulatory sequence.
- a promoter that is functional in the plant cell, operably linked to a target nucleic acid which is substantial identical and/or substantially complementary to at least 19 preferably at least 20,
- the present invention provides a method for producing a plant and/or a part thereof resistant to fungal pathogens of the family Phacosporaceae for example soybean rust comprising a) providing a recombinant nucleic acid comprising a target nucleic acid that is substantial identical and/or substantial complementary to at least contiguous 19 preferably at least 20, more preferably at least 21 , for example 22 or 23 nucleotides of the target sequence of the invention,
- target genes are preferably CTR1 , EBF1 and EBF2 and homologues, paralogues or functional equivalents thereof as for example defined by SEQ ID NO: 9, 1 1 , 13, 15, 17, 19, 21 or 23.
- the present invention further provides a vector construct comprising a recombinant nucleic acid comprising a promoter that is functional in the plant cell, operably linked to a target nucleic acid which is substantial identical and/or substantial complementary, preferably identical or complementary to at least 19 preferably at least 20, more preferably at least 21 , for example 22 or 23 contiguous nucleotides of the target gene of the invention and a terminator regulatory sequence as well as the use of the vector construct for the transformation of plants or parts thereof to provide plants resistant to fungal pathogens of the family Phacosporaceae for example soybean rust.
- the present invention also provides a transgenic plant cell, plants or parts thereof comprising a recombinant nucleic acid comprising a target nucleic acid that is substantial identical and/or substantial complementary, preferably identical or complementary to at least contiguous 19 preferably at least 20, more preferably at least 21 , for example 22 or 23 nucleotides of the target gene of the invention.
- Parts of plants may be plant cells, roots, stems, leaves, flowers and/or seeds.
- siRNA 19-24 nucleotide fragments
- RNA-interference RNA-interference
- miRNA micro-RNAi
- sense RNA sense RNA
- antisense RNA for downregulation or suppression of the expression of a target gene of the invention.
- RNAi refers to the process of sequence-specific post- transcriptional gene silencing, mediated by double-stranded RNA (dsRNA).
- dsRNA double-stranded RNA
- dsRNA comprising a first strand that is substantially complementary to at least 19 contiguous nucleotides of the target gene of the invention and a second strand that is complementary to the first strand at least partially has to be provided.
- a recombinant nucleic acid is introduced into the plant, which is capable to produce such dsRNA.
- the target gene- specific dsRNA is produced and processed into relatively small fragments (siRNAs).
- miRNA refers to a similar process, except that the produced dsRNA only partially comprises regions substantially identical to the target-gene (at least 19 contiguous nucleotides).
- antisense interference refers to the process of sequence-specific post- transcriptional gene silencing, probably also mediated by double-stranded RNA (dsRNA).
- dsRNA double-stranded RNA
- ssRNA comprising a first strand that is substantially complementary to at least 19 contiguous nucleotides of the target gene has to be provided.
- recombinant nucleic acid is introduced into the plant, which is capable to produce such ssRNA. Without to be bound by the theory, it is assumed that this RNA pairs with complementary ssRNA transcribed from the original target gene.
- the target nucleic acid comprises a 19-nucleotide portion which is substantially identical and/or substantially complementary to at least 19 contiguous nucleotides of the target gene.
- a target nucleic acid comprising a nucleotide sequence identical and/or identical to a portion of the target gene and/or complementary to the whole sequence and/or a portion of the target gene is preferred for inhibition, the invention can tolerate sequence variations that might be expected due to gene manipulation or synthesis, genetic mutation, strain polymorphism, or evolutionary divergence.
- the target nucleic acid may also encompass a mismatch with the target gene of at least 1 , 2, or more nucleotides.
- the target nucleic acid may contain an addition, deletion or substitution of 1 , 2, or more nucleotides, so long as the resulting RNA sequence still interferes with the respective target gene function.
- Sequence identity between the recombinant nucleic acid useful according to the present invention and the target gene may be optimized by sequence comparison and alignment algorithms known in the art (see Gribskov and Devereux, Sequence Analysis Primer, Stockton Press, 1991 , and references cited therein) and calculating the percent difference between the nucleotide sequences by, for example, the Smith-Waterman algorithm as implemented in the BESTFIT software program using default parameters (e.g., University of Wisconsin Genetic Computing Group). Greater than 80 % sequence identity, 90% sequence identity, or even 100% sequence identity, between the target nucleic acid and at least 19 contiguous nucleotides of the target gene is preferred. The same preferably applies for the sequence complementarity.
- the corresponding dsRNA provided therefrom will be cleaved randomly to dsRNAs of about 21 nucleotides within the plant cell: the siRNAs.
- Multiple specialized Dicers in plants may generate siRNAs typically ranging in size from 19nt to 24nt (See Henderson et al., 2006. Nature Genetics 38:721 -725.).
- the cleavage of a longer dsRNA of the invention may yield a pool of 21 mer dsRNAs, derived from the longer dsRNA.
- the siRNAs may have sequences corresponding to fragments of 19-24 contiguous nucleotides across the entire sequence of the target gene.
- the siRNA can have a mismatch with the target gene of at least 1 , 2, or more nucleotides. Further, these mismatches are intended to be included in the present invention.
- the target nucleic acid is substantial identical and/or substantial complementary, preferably identical or complementary over a length of at least 19, at least 50, at least 100, at least 200, at least 300, at least 400 or at least 500 nucleotides to the respective target gene.
- the target nucleic acid may comprise 19 to 500, preferably 50 to 500, more preferably 250 to 350 nucleotides, wherein preferably at least about 19, 20, 21 , 22, 23, 24, 25, 50, 100, 200, 300, 400, consecutive bases or up to the full length of target nucleic acid are identical and/or complementary and/or identical to the target gene.
- the recombinant nucleic acid is able to provide dsRNA and/or siRNA and/or miRNA in the plant, a part thereof once the recombinant nucleic acid is expressed in the plant, wherein preferably at least 19 contiguous nucleotides of the dsRNA and/or si RNA and/or miRNA are substantially complementary to the respective target gene.
- the term "substantially identical” or “substantially complementary” preferably refers to DNA and/or RNA which is at least 80% identical or complementary to 19 or more contiguous nucleotides of a specific DNA or RNA sequence of the respective target gene, more preferably, at least 90% identical to 19 or more contiguous nucleotides, and most preferably at least 95%, at least 96%, at least 97%, at least 98% or at least 99% identical or complementary or absolutely identical or absolutely complementary to 19 or more contiguous nucleotides of a specific DNA or RNA-sequence of the respective target gene.
- the identical RNA corresponds to the coding DNA-strand of the respective target gene.
- the term "substantially identical” or “substantially complementary” as applied to DNA of the recombinant nucleic acid, the target nucleic acid and/or the target gene means that the nucleotide sequence is at least 80% identical or complementary to 19 or more contiguous nucleotides of the target gene, more preferably, at least 90% identical or complementary to 19 or more contiguous nucleotides of the target gene, and most preferably at least 95%, at least 96%, at least 97%, at least 98% or at least 99% identical or complementary or absolutely identical or absolutely complementary to 19 or more contiguous nucleotides of the target gene.
- 19 or more contiguous nucleotides of the target gene corresponds to the target gene, being at least about 19, 20, 21 , 22, 23, 24, 25, 50, 100, 200, 300, 400, 500, 1000, 1500, con- secutive bases or up to the full length of the target gene.
- One embodiment according to the present invention provides a method for producing a plant and/or a part thereof resistant to a fungal pathogen of the family Phacosporaceae, for example soybean rust, wherein the recombinant nucleic acid comprises
- a target nucleic acid which is substantial identical and/or substantial complementary, or preferably identical or complementary to at least 19 preferably at least 20, more preferably at least 21 , for example 22 or 23 contiguous nucleotides of the respective target gene and which, when it is transcribed, generates RNA comprising a first strand having a sequence substantially comple- mentary to at least 19 preferably at least 20, more preferably at least 21 , for example 22 or 23 contiguous nucleotides of the target gene and a second strand having a sequence substantially complementary to the first strand and/or parts thereof, and
- the first strand and the second strand may at least partially form dsRNA. This technique is also referred to as RNAi.
- the target nucleic acid comprises 19 to 24 contiguous nucleotides of the target sequence which are substantially identical and/or substantially complementary to the tar- get gene and the remaining nucleotides of the target nucleic acid are not identical and/or not complementary to the target gene.
- Not-identical means an identity which is lower than 95%, lower that 90%, lower than 80%, lower than 70 %, lower than 60% over the whole sequence of the target nucleic acid.
- Not-complementary means a complementarity which is lower than 95%, lower that 90%, lower than 80%, lower than 70 %, lower than 60% over the whole sequence of the target nucleic acid. This technique is also referred to as miRNA.
- One embodiment according to the present invention provides a method for producing a plant and/or a part thereof resistant to a fungal pathogens of the family Phacosporaceae, for example soybean rust, wherein the recombinant nucleic acid comprises a promoter that is functional in the plant cell, operably linked to a
- target nucleic acid which, when it is transcribed, generates RNA comprising a first strand having a sequence substantially complementary, preferably complementary to at least contiguous 19 preferably at least 20, more preferably at least 21 , for example 22 or 23 nucleotides of the target gene, and a terminator regulatory sequence.
- the first strand generated in the plant forms dsRNA together with a second RNA- strand generated in the plant which is complementary to the first strand.
- This technique is also referred to as antisense RNA.
- the dsRNA of the invention may optionally comprise a single stranded overhang at either or both ends.
- the single stranded overhang comprises at least two nucleotides at the 3 ' end of each strand of the dsRNA molecule.
- the double-stranded structure may be formed by a single self-complementary RNA strand (i.e. forming a hairpin loop) or two complementary RNA strands.
- the dsRNA of the invention forms a hairpin loop, it may optionally comprise an intron, as set forth in US 2003/0180945A1 or a nucleotide spacer, which is a stretch of sequence between the complementary RNA strands to stabilize the hairpin transgene in cells.
- Methods for making various dsRNA molecules are set forth, for example, in WO 99/53050 and in U.S.Pat.No. 6,506,559.
- target nucleic acid which is substantial identical and/or substantial complementary to at least 19 preferably at least 20, more preferably at least 21 , for example 22 or 23 contiguous nucleotides of the target gene and which, when it is transcribed, generates RNA comprising a first strand having a sequence substantially complementary to at least 19 preferably at least 20, more preferably at least 21 , for example 22 or 23 contiguous nucleotides of the target gene and a second strand having a sequence at substantially complementary to the first strand or parts thereof, and a terminator regulatory sequence.
- first strand and the second strand are capable of hybridizing to form dsRNA at least partially.
- the vector construct comprises a promoter that is functional in the plant cell, operably linked to a target nucleic acid which, when it is transcribed, generates RNA comprising a first strand having a sequence substantially complementary or identical to at least 19 preferably at least 20, more preferably at least 21 , for example 22 or 23 contiguous nucleotides of the target gene, and a terminator regulatory sequence.
- the transcript of the first strand and at least a part of the transcript of the target gene are capable of hybridizing to form dsRNA at least partially.
- the vector construct comprises a target nucleic acid comprising 19 to 500 nucleotides. Further variants of the target nucleic acid are defined in the section referring to the method for producing a plant.
- the term "operatively linked” is intended to mean that the target nucleic acid is linked to the regulatory sequence, including promoters, terminators, enhancers and/or other expression control elements (e.g., poly- adenylation signals), in a manner which allows for expression of the target nucleic acid (e.g., in a host plant cell when the vector is introduced into the host plant cell).
- regulatory sequences are described, for example, in Goeddel, Gene Expression Technology: Methods in Enzymology 185, Academic Press, San Diego, CA (1990) and Gruber and Crosby, in: Methods in Plant Molecular Biology and Biotechnology, Eds.
- Regulatory sequences include those that direct constitutive expression of a nucleotide sequence in many types of host cells and those that direct expression of the nucleotide sequence only in certain host cells or under certain conditions. It will be appreciated by those skilled in the art that the design of the vector can depend on such factors as the choice of the host cell to be transformed, the level of expression of dsRNA desired, and the like.
- the vector constructs of the invention can be intro-ucked into plant host cells to thereby produce ssRNA, dsRNA, siRNA and/or mi RNA in order to prevent and/or reduce expression of the respective target gene and thereby increase resistance to fungal pathogens of the family Phacosporaceae, for example soybean rust.
- the vector construct comprises a promoter operatively linked to a target nucleotide that is a template for one or both strands of the ssRNA- or dsRNA molecules at least substantial complementary to 19 contiguous nucleotides of the target gene.
- the nucleic acid molecule further comprises two promoters flanking either end of the nucleic acid molecule, wherein the promoters drive expression of each individual DNA strand, thereby generating two complementary RNAs that hybridize and form the dsRNA.
- the nucleotide sequence is transcribed into both strands of the dsRNA on one transcription unit, wherein the sense strand is transcribed from the 5' end of the transcription unit and the antisense strand is transcribed from the 3' end, wherein the two strands are separated by about 3 to about 500 base pairs, and wherein after transcription, the RNA transcript folds on itself to form a hairpin.
- the vector contains a bidirectional promoter, driving expression of two nucleic acid molecules, whereby one nucleic acid molecule codes for the sequence substantially identical to a portion of a target gene of the invention and the other nucleic acid molecule codes for a second sequence being substantially complementary to the first strand and capable of forming a dsRNA, when both sequences are transcribed.
- a bidirectional promoter is a promoter capable of mediating expression in two directions.
- the vector contains two promoters, one mediating transcription of the sequence substantially identical to a portion of a target gene of the invention and another promoter mediating transcription of a second sequence being substantially complementary to the first strand and capable of forming a dsRNA, when both sequences are transcribed.
- the second promoter might be a different promoter.
- a different promoter means a promoter having a different activity in regard to cell or tissue specificity, or showing expression on different inducers for example, pathogens, abiotic stress or chemicals.
- Promoters according to the present invention may be constitutive, inducible, in particular patho- gen-inducible, developmental stage-preferred, cell type-preferred, tissue-preferred or organ- preferred.
- Constitutive promoters are active under most conditions.
- Non-limiting examples of constitutive promoters include the CaMV 19S and 35S promoters (Odell et al., 1985, Nature 313:810-812), the sX CaMV 35S promoter (Kay et al., 1987, Science 236:1299-1302), the Sep1 promoter, the rice actin promoter (McElroy et al., 1990, Plant Cell 2:163-171 ), the Arabidopsis actin promoter, the ubiquitin promoter (Christensen et al., 1989, Plant Molec.
- promoters from the T-DNA of Agrobacterium such as mannopine synthase, nopaline synthase, and octopine synthase, the small subunit of ribulose biphosphate carboxylase (ssuRUBISCO) promoter, and/or the like.
- Promoters that express the dsRNA in a cell that is contacted by fungus are preferred.
- the promoter may drive expression of the dsRNA in a plant tissue remote from the site of contact with the fungus, and the dsRNA may then be transported by the plant to a cell that is contacted by the fungus, in particular cells of, or close by fungal infected sites.
- the expression vector of the invention comprises a constitutive promoter, root- specific promoter, a pathogen inducible promoter, or a fungal-inducible promoter.
- a promoter is inducible, if its activity, measured on the amount of RNA produced under control of the promoter, is at least 30%, 40%, 50% preferably at least 60%, 70%, 80%, 90% more preferred at least 100%, 200%, 300% higher in its induced state, than in its un-induced state.
- a promoter is cell-, tissue- or organ-specific, if its activity , measured on the amount of RNA produced under control of the promoter, is at least 30%, 40%, 50% preferably at least 60%, 70%, 80%, 90% more preferred at least 100%, 200%, 300% higher in a particular cell-type, tissue or organ, then in other cell-types or tissues of the same plant, preferably the other cell-types or tissues are cell types or tissues of the same plant organ, e.g. a root.
- the promoter activity has to be compared to the promoter activity in other plant organs, e.g. leaves, stems, flowers or seeds.
- tissue and organ preferred promoters include those that are preferentially expressed in certain tissues or organs, such as leaves, roots, seeds, or xylem.
- tissue preferred and organ preferred promoters include, but are not limited to fruit-preferred, ovule- preferred, male tissue-preferred, seed-preferred, integument-preferred, tuber-preferred, stalk- preferred, pericarp-preferred, leaf-preferred, stigma-preferred, pollen-preferred, anther- preferred, a petal-preferred, sepal-preferred, pedicel-preferred, silique-preferred, stem- preferred, root-preferred promoters and/or the like.
- Seed preferred promoters are preferentially expressed during seed development and/or germination.
- seed preferred promot- ers can be embryo-preferred, endosperm preferred and seed coat-preferred. See Thompson et al., 1989, BioEssays 10:108.
- seed preferred promoters include, but are not limited to cellulose synthase (celA), Cim1 , gamma-zein, globulin-1 , maize 19 kD zein (cZ19B1 ) and/or the like.
- Other suitable tissue-preferred or organ-preferred promoters include, but are not limited to, the napin-gene promoter from rapeseed (U.S. Patent No.
- WO 91/13980 or the legumin B4 promoter (LeB4; Baeumlein et al., 1992, Plant Journal, 2(2):233- 9), as well as promoters conferring seed specific expression in monocot plants like maize, barley, wheat, rye, rice, etc.
- Suitable promoters to note are the Ipt2 or Ipt1 -gene promoter from bar- ley (PCT Application No. WO 95/15389 and PCT Application No. WO 95/23230) or those described in PCT Application No.
- WO 99/16890 promoters from the barley hordein-gene, rice glutelin gene, rice oryzin gene, rice prolamin gene, wheat gliadin gene, wheat glutelin gene, oat glutelin gene, Sorghum kasirin-gene, and/or rye secalin gene
- Promoters useful according to the invention include, but are not limited to, are the major chloro- phyll a/b binding protein promoter, histone promoters, the Ap3 promoter, the ⁇ -conglycin promoter, the napin promoter, the soybean lectin promoter, the maize 15kD zein promoter, the 22kD zein promoter, the 27kD zein promoter, the g-zein promoter, the waxy, shrunken 1 , shrunken 2, bronze promoters, the Zm13 promoter (U.S. Patent No. 5,086,169), the maize polygalacturonase promoters (PG) (U.S. Patent Nos. 5,412,085 and 5,545,546), the SGB6 pro- moter (U.S. Patent No. 5,470,359), as well as synthetic or other natural promoters.
- the major chloro- phyll a/b binding protein promoter include, but are not limited to, are the major chloro-
- Epidermisspezific promotors may be seleted from the group consisting of:
- GLP4 acc. AJ310534; Wei Y., Zhang Z., Andersen C.H., Schmelzer E., Gregersen P.L., Collin- ge D.B., Smedegaard-Petersen V. and Thordal-Christensen H., Plant Molecular Biology 36, 101 (1998),
- GLP2a acc. AJ237942, Schweizer P., Christoffel A. and Dudler R., Plant J. 20, 541 (1999); Prx7, acc. AJ003141 , Kristensen B.K., Ammitzboll H., Rasmussen S.K. and Nielsen K.A., Molecular Plant Pathology, 2(6), 31 1 (2001 );
- GerA acc. AF250933; Wu S., Druka A., Horvath H., Kleinhofs A., Kannangara G. and von Wettstein D., Plant Phys Biochem 38, 685 (2000);
- RTBV acc. AAV62708, AAV62707; Kloti A., Henrich C, Bieri S., He X., Chen G., Burkhardt P.K., Wunn J., Lucca P., Hohn T., Potrykus I. and Futterer J., PMB 40, 249 (1999);
- AtProT3 Promotor (Grallath et al., Plant Physiology. 137(1 ), 1 17 (2005));
- Mesophyllspezific promotors may be seleted from the group consisting of:
- PPCZml PEPC
- Kausch A.P. Owen T.P.
- Zachwieja S.J. Flynn A.R. and Sheen J., Plant
- TaGF-2.8 acc. M63223; Schweizer P., Christoffel A. and Dudler R., Plant J. 20, 541 (1999); TaFBPase, acc. X53957;
- HvPrx8 acc. AJ276227; Kristensen et al., Molecular Plant Pathology, 2(6), 31 1 (2001 ); and/or HvPAL, acc. X97313; Wei Y., Zhang Z., Andersen C.H., Schmelzer E., Gregersen P.L., Collinge D.B., Smedegaard-Petersen V. and Thordal-Christensen H. Plant Molecular Biology 36, 101 (1998).
- Constitutve promotors may be selected from the group consisting of
- CaMV 35S promoter Cauliflower Mosaic Virus 35S promoter (Benfey et al. 1989 EMBO J.
- STPT promoter Arabidopsis thaliana Short Triose phosphat translocator promoter (Accession NM_123979)
- Act1 promoter - Oryza sativa actin 1 gene promoter (McElroy et al. 1990 PLANT CELL 2(2) 163-171 a) and/or
- EF1A2 promoter Glycine max translation elongation factor EF1 alpha (US 20090133159).
- the methods of the invention for upregulation of Pti4, Pti5, ERF1 and/or ERF2 as defined above and downregulation of CTR1 , EBF1 and/or an EBF2 as defined above to increase Phacosporacea, for example soybean rust resistance in a plant by priming the ethylene signaling pathway may be combined and applied to one plant at a time.
- the vector or plant or plant part of the invention may comprise one or more constructs for overexpression of at least one of Pti4, Pti5, ERF1 and/or ERF2 and at the same time one or more constructs for downregulation of at least one of CTR1 , EBF1 and/or an EBF2.
- vector construct is a "plasmid,” which refers to a circular double stranded DNA loop into which additional DNA segments can be ligated.
- viral vector Another type of vector, wherein additional DNA segments can be ligated into the viral genome.
- Certain vector constructs are capable of autonomous replication in a host plant cell into which they are introduced. Other vector constructs are integrated into the genome of a host plant cell upon introduction into the host cell, and thereby are replicated along with the host genome. In particular the vector construct is capable of directing the expression of gene to which the vectors is operatively linked.
- the invention is intended to include such other forms of expression vector constructs, such as viral vectors (e.g., potato virus X, tobacco rattle virus, and/or Gemini virus), which serve equivalent functions.
- the target nucleic acid is capable to reduce the protein quantity or function of any of the proteins of the invention in plant cells.
- the decrease in the protein quantity or function of the target protein takes place in a constitutive or tissue-specific manner.
- an essentially pathogen- induced decrease in the protein quantity or protein function takes place, for example by recombinant expression of the target nucleic acid under the control of a fungal-inducible promoter.
- the expression of the target nucleic acid takes place on fungal infected sites, where, however, preferably the expression of the target nucleic acid sequence remains essentially unchanged in tissues not infected by fungus.
- the protein amount of a target protein in the plant is reduced by at least 10%, at least 20%, at least 30%, at least 40%, at least 50%, at least 60%, at least 70%, at least 80%, at least 90%, or at least 95% or more in comparison to a wild type plant that is not transformed with the target nucleic acid.
- the wild type plant is a plant of a similar, more preferably identical genotype as the plant transformed with the target nucleic acid.
- introduction or “transformation” as referred to herein encompass the transfer of an exogenous polynucleotide into a host cell, irrespective of the method used for transfer.
- Plant tissue capable of subsequent clonal propagation may be transformed with a vector construct of the present invention and a whole plant regenerated there from.
- the particular tissue chosen will vary depending on the clonal propagation systems available for, and best suited to, the particular species being transformed.
- Exemplary tis- sue targets include leaf disks, pollen, embryos, cotyledons, hypocotyls, megagametophytes, callus tissue, existing meristematic tissue (e.g., apical meristem, axillary buds, and root meris- tems), and induced meristem tissue (e.g., cotyledon meristem and hypocotyl meristem).
- the polynucleotide may be transiently or stably introduced into a host cell and may be maintained non-integrated, for example, as a plasmid. Alternatively, it may be integrated into the host ge- nome.
- the resulting transformed plant cell may then be used to regenerate a transformed plant in a manner known to persons skilled in the art.
- terminal encompasses a control sequence which is a DNA sequence at the end of a transcriptional unit which signals 3' processing and polyadenylation of a primary transcript and termination of transcription.
- the terminator can be derived from the natural gene, from a variety of other plant genes, or from T-DNA.
- the terminator to be added may be derived from, for example, the nopaline synthase or octopine synthase genes, or alternatively from another plant gene, or less preferably from any other eukaryotic gene.
- the transgenic plant cells may be transformed with one of the above described vector constructs. Suitable methods for transforming or transfecting host cells including plant cells are well known in the art of plant biotechnology. Any method may be used to transform the recombinant expression vector into plant cells to yield the transgenic plants of the invention. General methods for transforming dicotyledonous plants are disclosed, for example, in U.S. Pat. Nos.
- Transformation methods may include direct and indirect methods of transformation. Suitable direct methods include polyethylene glycol induced DNA uptake, liposome-mediated transformation (US 4,536,475), biolistic methods using the gene gun (Fromm ME et al., Bio/Technology.
- the plasmids used need not meet any particular requirements. Simple plasmids, such as those of the pUC series, pBR322, M13mp series, pACYC184 and the like can be used. If intact plants are to be regenerated from the transformed cells, an additional selectable marker gene is preferably located on the plasmid.
- the direct transformation techniques are equally suitable for dicotyledonous and monocotyle- donous plants.
- Transformation can also be carried out by bacterial infection by means of Agrobacterium (for example EP 0 1 16 718), viral infection by means of viral vectors (EP 0 067 553; US 4,407,956; WO 95/34668; WO 93/03161 ) or by means of pollen (EP 0 270 356; WO 85/01856; US
- Agrobacterium based transformation techniques (especially for dicotyledonous plants) are well known in the art.
- the Agrobacterium strain e.g., Agrobacterium tumefaciens or Agrobacterium rhizogenes
- the Agrobacterium strain comprises a plasmid (Ti or Ri plasmid) and a T-DNA element which is transferred to the plant following infection with Agrobacterium.
- the T-DNA (transferred DNA) is integrated into the genome of the plant cell.
- the T-DNA may be localized on the Ri- or Ti- plasmid or is separately comprised in a so-called binary vector.
- the Agro bacterium-mediated transformation is best suited to dicotyledonous plants but has also been adapted to monocotyledonous plants.
- the transformation of plants by Agro- bacteria is described in, for example, White FF, Vectors for Gene Transfer in Higher Plants, Transgenic Plants, Vol. 1 , Engineering and Utilization, edited by S.D. Kung and R. Wu, Academic Press, 1993, pp. 15 - 38; Jenes B et al. Techniques for Gene Transfer, Transgenic Plants, Vol. 1 , Engineering and Utilization, edited by S.D. Kung and R. Wu, Academic Press, 1993, pp. 128-143; Potrykus (1991 ) Annu Rev Plant Physiol Plant Molec Biol 42:205- 225.
- Transformation may result in transient or stable transformation and expression.
- a nu- cleotide sequence of the present invention can be inserted into any plant and plant cell falling within these broad classes, it is particularly useful in crop plant cells.
- the genetically modified plant cells can be regenerated via all methods with which the skilled worker is familiar. Suitable methods can be found in the abovementioned publications by S.D. Kung and R. Wu, Potrykus or Hofgen and Willmitzer.
- plant cells or cell groupings are selected for the presence of one or more markers which are encoded by plant-expressible genes co-transferred with the gene of interest, following which the transformed material is regenerated into a whole plant.
- the plant material obtained in the transformation is, as a rule, subjected to selective conditions so that transformed plants can be distinguished from untransformed plants.
- the seeds obtained in the above-described manner can be planted and, after an initial growing period, subjected to a suitable selection by spraying.
- a further possibility consists in growing the seeds, if appropriate after sterilization, on agar plates using a suitable selection agent so that only the transformed seeds can grow into plants.
- the transformed plants are screened for the presence of a selectable marker such as the ones described above.
- putatively transformed plants may also be evaluated, for instance using Southern analysis, for the presence of the gene of interest, copy number and/or genomic organisation. Alternatively or additionally, expression levels of the newly introduced DNA may be monitored using Northern and/or Western analysis, both techniques being well known to persons having ordinary skill in the art.
- the generated transformed plants may be propagated by a variety of means, such as by clonal propagation or classical breeding techniques. For example, a first generation (or T1 ) transformed plant may be selfed and homozygous second-generation (or T2) transformants selected, and the T2 plants may then further be propagated through classical breeding techniques.
- the generated transformed organisms may take a variety of forms.
- they may be chi- meras of transformed cells and non-transformed cells; clonal transformants (e.g., all cells transformed to contain the expression cassette); grafts of transformed and untransformed tissues (e.g., in plants, a transformed rootstock grafted to an untransformed scion).
- clonal transformants e.g., all cells transformed to contain the expression cassette
- grafts of transformed and untransformed tissues e.g., in plants, a transformed rootstock grafted to an untransformed scion.
- Harvestable parts of the transgenic plant according to the present invention are part of the in- vention.
- the harvestable parts may be seeds, roots, leaves and/or flowers comprising the
- soy plants are soy beans comprising the transgenic SMT1 -gene.
- Products derived from transgenic plant according to the present invention, parts thereof or har- vestable parts thereof are part of the invention.
- a preferred product is soybean meal or soybean oil.
- the present invention also includes methods for the production of a product comprising a) growing the plants of the invention and b) producing said product from or by the plants of the inven- tion and/or parts thereof, e.g. seeds, of these plants.
- the method comprises the steps a) growing the plants of the invention, b) removing the harvestable parts as defined above from the plants and c) producing said product from or by the harvestable parts of the invention.
- the method for the production of a product comprises
- the plants of the invention may be grown at the site where the plant has been grown, the plants and/or parts thereof may be removed from the site where the plants have been grown to produce the product.
- the plant is grown, the desired harvestable parts are removed from the plant, if feasible in repeated cycles, and the product made from the harvestable parts of the plant.
- the step of growing the plant may be performed only once each time the methods of the invention is performed, while allowing repeated times the steps of product production e.g. by repeated removal of harvestable parts of the plants of the invention and if necessary further processing of these parts to arrive at the product.
- step of growing the plants of the invention is repeated and plants or harvestable parts are stored until the production of the product is then performed once for the accumulated plants or plant parts.
- steps of growing the plants and producing the product may be performed with an overlap in time, even simultaneously to a large extend or sequentially. Generally the plants are grown for some time before the product is produced.
- the products produced by said methods of the invention are plant products such as, but not limited to, a foodstuff, feedstuff, a food supplement, feed supplement, fiber, cosmetic and/or pharmaceutical.
- Foodstuffs are regarded as compositions used for nutrition and/or for supplementing nutrition.
- Animal feedstuffs and animal feed supplements, in particular, are regarded as foodstuffs.
- inventive methods for the production are used to make agricultural products such as, but not limited to, plant extracts, proteins, amino acids, carbohydrates, fats, oils, polymers, vitamins, and the like.
- a plant product consists of one ore more agricultural products to a large extent.
- FIG. 1 shows the schematic illustration of the ET signaling pathway (taken from Adie et al. J Plant Growth Regul 2007 26:160ff, DOI 10.1007/s00344-007-0012-6). Binding of ET leads to inactivation of its receptor and in turn to the deactivation of the Raf-like kinase CTRL This allows EIN2 to activate the Ein3 family of transcription factors. On the other hand Ein3 is regu- lated by EBF1 and EBF2, leading to the degradation of EIN3. Activated Ein3 up-regulates the expression of ERF1 (and his homologous / orthologous genes). ERF1 (and other ERF-like transcription factors) activate the expression of ethylene regulated defense genes (e.g. PR proteins etc.).
- Figure 2 shows the scoring system used to determine the level of diseased leaf area of wildtype and transgenic soy plants against the rust fungus P. pachyrhizi.
- Figure 3 shows the full-length-sequence of the ERF-1 -gene from Arabidopsis thaliana having SEQ-ID-No.1 .
- Figure 4 shows the sequence of the ERF-1 -protein (SEQ-ID-2).
- Figure 5 shows the result of the scoring of 31 transgenic soy plants expressing the ERF-1 over- expression vector construct.
- TO soybean plants expressing ERF-1 protein were inoculated with spores of Phakopsora pachyrhizi. The evaluation of the diseased leaf area on all leaves was performed 14 days after inoculation. The average of the percentage of the leaf area showing fungal colonies or strong yellowing/browning on all leaves was considered as diseased leaf ar- ea.
- At all 31 soybean TO plants expressing ERF-1 (expression checked by RT-PCR) were evaluated in parallel to non-transgenic control plants. The median of the diseased leaf area is shown in Fig 5.
- FIG. 6 shows the full-length-sequence of the Pti-4-gene from Solanum lycopersicum having SEQ-ID-No.3.
- FIG. 7 shows the sequence of the Pti-4-protein (SEQ-ID-4).
- Figure 8 shows the result of the scoring of 33 transgenic soy plants expressing the Pti-4 over- expression vector construct.
- TO soybean plants expressing Pti-4 protein were inoculated with spores of Phakopsora pachyrhizi. The evaluation of the diseased leaf area on all leaves was performed 14 days after inoculation. The average of the percentage of the leaf area showing fungal colonies or strong yellowing/browning on all leaves was considered as diseased leaf ar- ea.
- At all 33 soybean TO plants expressing Pti-4 (expression checked by RT-PCR) were evaluated in parallel to non-transgenic control plants. The median of the diseased leaf area is shown in Fig 8.
- FIG. 9 shows the full-length-sequence of the Pti-5-gene from Solanum lycopersicum having SEQ-ID-No.5.
- Figure 10 shows the sequence of the Pti-5-protein (SEQ-ID-6).
- Figure 11 shows the result of the scoring of 34 transgenic soy plants expressing the Pti-5 over- expression vector construct.
- TO soybean plants expressing Pti-5 protein were inoculated with spores of Phakopsora pachyrhizi. The evaluation of the diseased leaf area on all leaves was performed 14 days after inoculation. The average of the percentage of the leaf area showing fungal colonies or strong yellowing/browning on all leaves was considered as diseased leaf ar- ea.
- At all 34 soybean TO plants expressing Pti-4 were evaluated in parallel to non-transgenic control plants. The median of the diseased leaf area is shown in Fig 1 1 .
- FIG. 12 shows the full-length-sequence of the ERF-2-gene from Arabidopsis thaliana having SEQ-ID-No.7.
- FIG. 13 shows the sequence of the ERF-2-protein (SEQ-ID-8).
- Figure 14 shows the result of the scoring of 29 transgenic soy plants expressing the ERF-2 overexpression vector construct.
- TO soybean plants expressing ERF-2 protein were inoculated with spores of Phakopsora pachyrhizi. The evaluation of the diseased leaf area on all leaves was performed 14 days after inoculation. The average of the percentage of the leaf area showing fungal colonies or strong yellowing/browning on all leaves was considered as diseased leaf area.
- At all 29 soybean TO plants expressing ERF-2 (expression checked by RT-PCR) were evaluated in parallel to non-transgenic control plants. The median of the diseased leaf area is shown in Fig 14. Overexpression of ERF-2 significantly (p ⁇ 0.01 ) reduces the diseased leaf area in comparison to non-transgenic control plants.
- Figure15 shows the full-length-sequence of the CTR-1 -gene from Arabidopsis thaliana having SEQ-ID-No.9
- Figure 16 shows the sequence of the CTR-1 -protein (SEQ-ID-10).
- Figure17 shows the full-length-sequence of the EBF-1 -gene from Arabidopsis thaliana having SEQ-ID-No.1 1
- Figure 18 shows the sequence of the EBF-1 -protein (SEQ-ID-12).
- Example 1 General methods The chemical synthesis of oligonucleotides can be affected, for example, in the known fashion using the phosphoamidite method (Voet, Voet, 2nd Edition, Wiley Press New York, pages 896- 897).
- the cloning steps carried out for the purposes of the present invention such as, for example, restriction cleavages, agarose gel electrophoresis, purification of DNA fragments, transfer of nucleic acids to nitrocellulose and nylon membranes, linking DNA fragments, transformation of E. coli cells, bacterial cultures, phage multiplication and sequence analysis of recombinant DNA, are carried out as described by Sambrook et al. Cold Spring Harbor Laboratory Press (1989), ISBN 0-87969-309-6.
- the sequencing of recombinant DNA molecules is carried out with an MWG-Licor laser fluorescence DNA sequencer following the method of Sanger (Sanger et al., Proc. Natl. Acad. Sci. USA 74, 5463 (1977)).
- cDNAs of all genes mentioned in this application were generated by DNA synthesis (Ge- neart, Regensburg, Germany).
- the ERF1 cDNA was synthesized in a way that a EcoRV restriction site is located in front of the start-ATG and a Spel restriction site downstream of the stop-codon.
- the synthesized cDNA were digested using the restriction enzymes EcoRV and Spel (NEB Biolabs) and ligated in a EcoRV/Spel digested Gateway pENTRY vector (Invitrogen, Life Technologies, Carlsbad, California, USA) in a way that the full-length fragment is located in sense direction between the parsley ubiquitine promoter (PcUbi) and a Agrobacterium tOCS terminator.
- a triple LR reaction (Gateway system, (Invitrogen, Life Technologies, Carlsbad, California, USA) was performed according to manufacturers protocol by using a pENTRY-A vector containing a parsley ubiquitine promoter, the above described pENTRY-B vector containing the cDNA and a pENTRY-C vector containing a t- StCatpA terminator.
- a binary pDEST vector was used which is composed of: (1 ) a Kanamycin resistance cassette for bacterial selection (2) a pVS1 origin for replication in Agrobacteria (3) a pBR322 origin of replication for stable maintenance in E.
- the Pti4, Pti5, CTR1 cDNA were synthesized in a way that an attB1 -recombination site (Gate- way system, (Invitrogen, Life Technologies, Carlsbad, California, USA) is located in front of the start-ATG and a attB2 recombination site is located directly downstream of the stop-codon.
- the synthesized cDNAs were transferred to a pENTRY-B vector by using the BP reaction (Gateway system, (Invitrogen, Life Technologies, Carlsbad, California, USA ) according to the protocol provided by the supplier.
- a triple LR reaction (Gateway system, (Invitrogen, Life Technologies, Carlsbad, California, USA) was performed according to manufacturers protocol by using a pENTRY-A vector containing a parsley ubiq- uitine promoter, the cDNAs in a pENTRY-B vector and a pENTRY-C vector containing a t-Nos terminator.
- a binary pDEST vector was used which is composed of: (1 ) a Kanamycin resistance cassette for bacterial selection (2) a pVS1 origin for replication in Agrobacteria (3) a pBR322 origin of replication for stable maintenance in E.
- the EFB1 and ERF2 cDNA were synthesized in a way that an EcoRV restriction site is located in front of the start-ATG and a Spel restriction site downstream of the stop-codon.
- the synthesized cDNAs were digested using the restriction enzymes EcoRV and Spel (NEB Biolabs) and ligated in a EcoRV/Spel digested Gateway pENTRY vector (Invitrogen, Life Technologies, Carlsbad, California, USA) in a way that the full-length fragment is located in sense direction between the parsley ubiquitine promoter (PcUbi) and a Agrobacterium tOCS terminator.
- a triple LR reaction (Gateway system, (Invitrogen, Life Technologies, Carlsbad, California, USA) was performed according to manufacturers proto- col by using an empty pENTRY-A vector containing no sequence between the recombination sites, the above described pENTRY-B vector containing the cDNAs ,and an empty pENTRY-C vector.
- a binary pDEST vector was used which is composed of: (1 ) a Kanamycin resistance cassette for bacterial selection (2) a pVS1 origin for replication in Agrobacteria (3) a pBR322 origin of replication for stable maintenance in E.
- any seed of any soy variety can be employed in the method of the invention.
- a variety of soycultivar (including Jack, Williams 82, and Resnik) is appropriate for soy transformation. Soy seeds were sterilized in a chamber with a chlorine gas produced by adding 3.5 ml 12N HCI drop wise into 100 ml bleach (5.25% sodium hypochlorite) in a desiccator with a tightly fitting lid. After 24 to 48 hours in the chamber, seeds were removed and approximately 18 to 20 seeds were plated on solid GM medium with or without 5 ⁇ 6-benzyl-aminopurine (BAP) in 100 mm Petri dishes. Seedlings without BAP are more elongated and roots develop, especially secon- dary and lateral root formation. BAP strengthens the seedling by forming a shorter and stockier seedling.
- the hypocotyl and one and a half or part of both cotyledons were removed from each seedling.
- the seedlings were then placed on propagation media for 2 to 4 weeks.
- the seedlings produce several branched shoots to obtain explants from.
- the majority of the explants originated from the plantlet growing from the apical bud. These explants were preferably used as target tissue.
- Agrobacterium cultures were prepared by streaking Agrobacterium (e.g., A. tumefaciens or A. rhizogenes) carrying the desired binary vector (e.g. H. Klee. R. Horsch and S. Rogers 1987 Ag- robacterium-Mediated Plant Transformation and its further Applications to Plant Biology; Annual Review of Plant Physiology Vol. 38: 467-486) onto solid YEP growth medium YEP media: 10 g yeast extract. 10 g Bacto Peptone. 5 g NaCI. Adjust pH to 7.0, and bring final volume to 1 liter with H20, for YEP agar plates add 20g Agar, autoclave) and incubating at 25. degree C. until colonies appeared (about 2 days).
- Agrobacterium e.g., A. tumefaciens or A. rhizogenes
- the desired binary vector e.g. H. Klee. R. Horsch and S. Rogers 1987 Ag- robacterium
- the binary vector and the bacterial chromosomes
- different selection compounds were be used for A. tumefaciens and rhizogenes selection in the YEP solid and liquid media.
- Various Agrobacterium strains can be used for the transformation method.
- the day before explant inoculation 200 ml of YEP were inoculated with 5 .mu.l to 3 ml of work- ing Agrobacterium stock in a 500 ml Erlenmeyer flask. The flask was shaked overnight at 25. degree. C. until the OD. sub.600 was between 0.8 and 1 .0.
- the Agrobacteria were pelleted by centrifugation for 10 min at 5,500.times.g at 20. degree. C. The pellet was resuspended in liquid CCM to the desired density (OD. sub.600 0.5-0.8) and placed at room temperature at least 30 min before use.
- Soyepicotyl segments prepared from 4 to 8 d old seedlings were used as explants for regeneration and transformation. Seeds of soyacv L00106CN, 93-41 131 and Jack were germinated in 1/10 MS salts or a similar composition medium with or without cytokinins for 4. about.8 d.
- Epicotyl explants were prepared by removing the cotyledonary node and stem node from the stem section. The epicotyl was cut into 2 to 5 segments. Especially preferred are segments attached to the primary or higher node comprising axillary meristematic tissue.
- the explants were used for Agrobacterium infection.
- Agrobacterium AGL1 harboring a plasmid with the construct of the invention and the AHAS, bar or dsdA selectable marker gene was cul- tured in LB medium with appropriate antibiotics overnight, harvested and resuspended in a inoculation medium with acetosyringone .
- Freshly prepared epicotyl segments were soaked in the Agrobacterium suspension for 30 to 60 min and then the explants were blotted dry on sterile filter papers.
- the inoculated explants were then cultured on a co-culture medium with L-cysteine and TTD and other chemicals such as acetosyringone for enhancing T-DNA delivery for 2 to 4 d.
- the infected epicotyl explants were then placed on a shoot induction medium with selection agents such as imazapyr (for AHAS gene), glufosinate (for bar gene), or D-serine (for dsdA gene).
- the regenerated shoots were subcultured on elongation medium with the selective agent.
- the segments were then cultured on a medium with cyto- kinins such as BAP, TDZ and/or Kinetin for shoot induction. After 4 to 8 weeks, the cultured tissues were transferred to a medium with lower concentration of cytokinin for shoot elongation. Elongated shoots were transferred to a medium with auxin for rooting and plant development. Multiple shoots were regenerated.
- the cotyledon was removed from the hypocotyl.
- the cotyledons were separated from one another and the epicotyl is removed.
- the primary leaves, which consist of the lamina, the petiole, and the stipules, were removed from the epicotyl by carefully cutting at the base of the stipules such that the axillary meristems were included on the explant.
- any pre-formed shoots were removed and the area between the stipules was cut with a sharp scalpel 3 to 5 times.
- the explants are either completely immersed or the wounded petiole end dipped into the Agro- bacterium suspension immediately after explant preparation. After inoculation, the explants are blotted onto sterile filter paper to remove excess Agrobacterium culture and place explants with the wounded side in contact with a round 7 cm Whatman paper overlaying the solid CCM me- dium (see above). This filter paper prevents A. tumefaciens overgrowth on the soyexplants. Wrap five plates with Parafilm.TM. "M” (American National Can, Chicago, III., USA) and incubate for three to five days in the dark or light at 25. degree. C.
- Axillary meristem explants can be pre-pared from the first to the fourth node. An average of three to four explants could be obtained from each seedling.
- the explants were prepared from plantlets by cutting 0.5 to 1 .0 cm below the axillary node on the internode and re- moving the petiole and leaf from the explant. The tip where the axillary meristems lie was cut with a scalpel to induce de novo shoot growth and allow access of target cells to the Agrobacterium. Therefore, a 0.5 cm explant included the stem and a bud.
- the explants were immediately placed in the Agrobacterium suspension for 20 to 30 minutes. After inoculation, the explants were blotted onto sterile filter paper to remove excess Agrobacterium culture then placed almost completely immersed in solid CCM or on top of a round 7 cm filter paper overlaying the solid CCM, depending on the Agrobacterium strain. This filter paper prevents Agrobacterium overgrowth on the soyexplants. Plates were wrapped with Parafilm.TM. "M” (American National Can, Chicago, III., USA) and incubated for two to three days in the dark at 25. degree. C.
- the explant For leaf explants (Method B), the explant should be placed into the medium such that it is per- pendicular to the surface of the medium with the petiole imbedded into the medium and the lamina out of the medium.
- Method C For propagated axillary meristem (Method C), the explant was placed into the medium such that it was parallel to the surface of the medium (basipetal) with the explant partially embedded into the medium.
- all shoots formed before transformation were removed up to 2 weeks after co- cultivation to stimulate new growth from the meristems. This helped to reduce chimerism in the primary transformant and increase amplification of transgenic meristematic cells.
- the explant may or may not be cut into smaller pieces (i.e. detaching the node from the explant by cutting the epicotyl).
- the explants were transfer to fresh SEM medium (preferably containing selection) after carefully removing dead tissue. The explants should hold together and not fragment into pieces and retain somewhat healthy. The explants were continued to be transferred until the explant dies or shoots elongate. Elongated shoots >3 cm were removed and placed into RM medium for about 1 week (Method A and B), or about 2 to 4 weeks depending on the cultivar (Method C) at which time roots began to form. In the case of explants with roots, they were transferred directly into soil. Rooted shoots were transferred to soil and hardened in a growth chamber for 2 to 3 weeks before transferring to the greenhouse. Regenerated plants obtained using this method were fertile and produced on average 500 seeds per plant.
- SEM medium preferably containing selection
- Transient expression of the construct of the invention after 5 days of co-cultivation with Agro- bacterium tumefaciens was widespread on the seedling axillary meristem explants especially in the regions wounding during explant preparation (Method A). Explants were placed into shoot induction medium without selection to see how the primary-node responds to shoot induction and regeneration. Thus far, greater than 70% of the explants were formed new shoots at this region. Expression of the construct of the invention was stable after 14 days on SIM, implying integration of the T-DNA into the soy genome. In addition, preliminary experiments resulted in the formation of positive shoots expressing the construct of the invention forming after 3 weeks on SIM .
- Method C the average regeneration time of a soyplantlet using the propagated axillary meristem protocol was 14 weeks from explant inoculation. Therefore, this method has a quick re- generation time that leads to fertile, healthy soyplants.
- the rust fungus is a wild isolate from Brazil.
- the plants were inoculated with P.pachyrhizi .
- soyleaves which had been infected with rust 15-20 days ago, were taken 2-3 days before the inoculation and transferred to agar plates (1 % agar in H20). The leaves were placed with their upper side onto the agar, which allowed the fungus to grow through the tissue and to produce very young spores. For the inoculation solution, the spores were knocked off the leaves and were added to a Tween-H20 solution. The counting of spores was performed under a light microscope by means of a Thoma counting chamber.
- the spore suspension was added into a compressed-air operated spray flask and applied uniformly onto the plants or the leaves until the leaf surface is well moisturized.
- a spore density of 1 - 5x105 spores/ml For macroscopic assays we used a spore density of 1 - 5x105 spores/ml.
- a density of >5 x 105 spores / ml is used.
- the inoculated plants were placed for 24 hours in a greenhouse chamber with an average of 22°C and >90% of air humidity. The following cultivation was performed in a chamber with an average of 25°C and 70% of air humidity.
- Example 5 Microscopical screening: For the evaluation of the pathogen development, the inoculated leaves of plants were stained with aniline blue 48 hours after infection.
- the aniline blue staining serves for the detection of fluorescent substances.
- substances such as phenols, callose or lignin accumulated or were produced and were incorporated at the cell wall either locally in pa- pillae or in the whole cell (hypersensitive reaction, HR).
- Complexes were formed in association with aniline blue, which lead e.g. in the case of callose to yellow fluorescence.
- the progression of the soybean rust disease was scored by the estimation of the diseased area (area which was covered by sporulating uredinia) on the backside (abaxial side) of the leaf. Additionally the yellowing of the leaf was taken into account, (for scheme see Figure 2)
- RNAi constructs targeting GmCTRI a (SEQ ID 13), GmCTRI b (SEQ ID 15) or GmCTRI c (SEQ ID 17) individually or all three homologous genes respectively.
- the RNAi constructs are synthesized and subsequently cloned into transformation vectors under the control of constitutive, pathogen inducible, leaf specific and/or epidermis specific promoters.
- the RNAi constructs are SEQ ID 25, targeting GmCTRI a, SEQ ID 26 targeting GmCTRI b, SEQ ID 27 targeting GmCTRI c and SEQ ID28 targeting GmCTRI a, b and c.
- the transgenic plants are analysed by RTqPCR for downregulation of the respective gene/s. Plants showing strong repression of CTR1 expression are inoculated with spores of Phakopsora pachyrhizi. The macroscopic disease symptoms of soy against P. pachyrhizi of up to 30 TO soybean plants per construct are scored 14 days after inoculation.
- the average of the percentage of the leaf area showing fungal colonies or strong yellowing/browning on all leaves is considered as diseased leaf area.
- All soybean TO plants exhibiting repression of CTR1 a, b or c or CTR1 a and b and c are evaluated in parallel to non-transgenic control plants. Clones from non-transgenic soy plants are used as control. Repression of CTR1 expression reduces the diseased leaf area in comparison to non-transgenic control plants significantly. The repression of CTR1 expression and therefore the priming of the ethylene signaling pathway in soy enhance the resistance of soy against soybean rust.
- Transgenic TO soybean plants are produced expressing a recombinant microRNA precursor comprising a microRNA targeting all three homologous GmCTRI a (SEQ ID 13), GmCTRI b (SEQ ID 15) and GmCTRI c (SEQ ID 17) genes.
- the microRNA precursor is synthesized and subsequently cloned into transformation vectors under the control of constitutive, pathogen inducible, leaf specific and/or epidermis specific promoters.
- the microRNA precursor is shown in SEQ ID 33.
- the transgenic plants are analyzed by RTqPCR for downregulation of the CTR1 homologues. Plants showing strong repression of CTR1 expression are inoculated with spores of Phakopsora pachyrhizi. The macroscopic disease symptoms of soy against P. pachyrhizi of up to 30 TO soybean plants are scored 14 days after inoculation.
- RNAi constructs targeting GmEBFI a SEQ ID 19
- GmEBFI b SEQ ID 21
- GmEBFI c SEQ ID 23
- RNAi constructs are SEQ ID 29, targeting GmEBFI a, SEQ ID 30 targeting GmEBFI b, SEQ ID 31 targeting.
- the transgenic plants are analyzed by RTqPCR for downregulation of the respective gene. Plants showing strong repression of expression of the respective GmEBFI gene are inoculated with spores of Phakopsora pachyrhizi. The macroscopic disease symptoms of soy against P. pachyrhizi of up to 30 TO soybean plants per construct are scored 14 days after inoculation. The average of the percentage of the leaf area showing fungal colonies or strong yellow- ing/browning on all leaves is considered as diseased leaf area. All soybean TO plants exhibiting repression of EBF1 a, b or c respectively are evaluated in parallel to non-transgenic control plants. Clones from non-transgenic soy plants are used as control. Repression of EBF1 expression reduces the diseased leaf area in comparison to non-transgenic control plants significantly. The repression of EBF1 expression and therefore the priming of the ethylene signaling pathway in soy enhance the resistance of soy against soybean rust.
- Transgenic TO soybean plants are produced expressing a recombinant microRNA precursor comprising a microRNA targeting all three homologous GmEBFI a (SEQ ID 19), GmEBFI b (SEQ ID 21 ) and GmEBFI c (SEQ ID 23) genes.
- the microRNA precursor is synthesized and subsequently cloned into transformation vectors under the control of constitutive, pathogen inducible, leaf specific and/or epidermis specific promoters.
- the microRNA precursor is shown in SEQ ID 32.
- the transgenic plants are analyzed by RTqPCR for downregulation of the EBF1 homologues. Plants showing strong repression of EBF1 expression are inoculated with spores of Phakopsora pachyrhizi. The macroscopic disease symptoms of soy against P. pachyrhizi of up to 30 TO soybean plants are scored 14 days after inoculation.
- the average of the percentage of the leaf area showing fungal colonies or strong yellowing/browning on all leaves is considered as diseased leaf area.
- All soybean TO plants exhibiting repression of EBF1 are evaluated in parallel to non-transgenic control plants. Clones from non- transgenic soy plants are used as control. Repression of EBF1 expression reduces the diseased leaf area in comparison to non-transgenic control plants significantly. The repression of EBF1 expression and therefore the priming of the ethylene signaling pathway in soy enhance the resistance of soy against soybean rust.
Landscapes
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Cell Biology (AREA)
- Botany (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Abstract
Description
Claims
Priority Applications (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US14/128,142 US9765356B2 (en) | 2011-06-27 | 2012-06-25 | Phacosporacea resistant soybean plants |
AU2012277381A AU2012277381A1 (en) | 2011-06-27 | 2012-06-25 | Phacosporacea resistant soybean plants |
CN201280032245.1A CN103620037A (en) | 2011-06-27 | 2012-06-25 | Phacosporacea resistant soybean plants |
BR112013033494-0A BR112013033494B1 (en) | 2011-06-27 | 2012-06-25 | METHOD FOR INCREASING THE RESISTANCE TO PHACOSPORACEA SOY RUST IN SOYBEAN PLANTS, METHOD FOR THE PRODUCTION OF A SOYBEAN PLANT THAT HAS INCREASED RESISTANCE AGAINST PHACOSPORACEA SOY RUST AND THE TRANSFORMATION VECTOR |
EP12805174.5A EP2723867A1 (en) | 2011-06-27 | 2012-06-25 | Phacosporacea resistant soybean plants |
CA2838795A CA2838795A1 (en) | 2011-06-27 | 2012-06-25 | Phacosporacea resistant soybean plants |
US15/691,031 US10696981B2 (en) | 2011-06-27 | 2017-08-30 | Phacosporacea resistant soybean plants |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201161501274P | 2011-06-27 | 2011-06-27 | |
US61/501274 | 2011-06-27 | ||
EP11171484 | 2011-06-27 | ||
EP11171484.6 | 2011-06-27 |
Related Child Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US14/128,142 A-371-Of-International US9765356B2 (en) | 2011-06-27 | 2012-06-25 | Phacosporacea resistant soybean plants |
US15/691,031 Continuation US10696981B2 (en) | 2011-06-27 | 2017-08-30 | Phacosporacea resistant soybean plants |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2013001435A1 true WO2013001435A1 (en) | 2013-01-03 |
Family
ID=47423487
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IB2012/053193 WO2013001435A1 (en) | 2011-06-27 | 2012-06-25 | Phacosporacea resistant soybean plants |
Country Status (8)
Country | Link |
---|---|
US (2) | US9765356B2 (en) |
EP (1) | EP2723867A1 (en) |
CN (1) | CN103620037A (en) |
AR (1) | AR087160A1 (en) |
AU (1) | AU2012277381A1 (en) |
BR (1) | BR112013033494B1 (en) |
CA (1) | CA2838795A1 (en) |
WO (1) | WO2013001435A1 (en) |
Cited By (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2014118018A1 (en) * | 2013-01-29 | 2014-08-07 | Basf Plant Science Company Gmbh | Fungal resistant plants expressing ein2 |
WO2014117988A1 (en) * | 2013-01-29 | 2014-08-07 | Basf Plant Science Company Gmbh | Fungal resistant plants expressing hcp7 |
WO2014117990A1 (en) * | 2013-01-29 | 2014-08-07 | Basf Plant Science Company Gmbh | Fungal resistant plants expressing hcp6 |
WO2014165066A3 (en) * | 2013-03-13 | 2014-11-27 | E. I. Dupont De Nemours & Company | Identification of p. pachyrhizi protein effectors and their use in producing asian soybean rust (asr) resistant plants |
US9688999B2 (en) | 2012-04-05 | 2017-06-27 | Basf Plant Science Company Gmbh | Fungal resistant plants expressing ACD |
US9944946B2 (en) | 2012-08-09 | 2018-04-17 | Basf Plant Science Company Gmbh | Fungal resistant plants expressing HCP4 |
US9957522B2 (en) | 2012-11-13 | 2018-05-01 | Basf Plant Science Company Gmbh | Fungal resistant plants expressing CASAR |
US10023875B2 (en) | 2012-08-09 | 2018-07-17 | Basf Plant Science Company Gmbh | Fungal resistant plants expressing HCP5 |
US10066239B2 (en) | 2012-08-09 | 2018-09-04 | Basf Plant Science Company Gmbh | Fungal resistant plants expressing RLK2 |
WO2019016323A1 (en) * | 2017-07-20 | 2019-01-24 | Rijk Zwaan Zaadteelt En Zaadhandel B.V. | Genetic basis for pythium resistance |
US10329580B2 (en) | 2012-08-09 | 2019-06-25 | Basf Plant Science Company Gmbh | Fungal resistant plants expressing RLK1 |
US10329579B2 (en) | 2011-12-23 | 2019-06-25 | Basf Plant Science Company Gmbh | Genes to enhance disease resistance in crops |
US10344296B2 (en) | 2012-04-05 | 2019-07-09 | Basf Plant Science Company Gmbh | Fungal resistant plants expressing hydrophobin |
US10465204B2 (en) | 2013-03-08 | 2019-11-05 | Basf Plant Science Company Gmbh | Fungal resistant plants expressing MybTF |
US10494643B2 (en) | 2012-04-11 | 2019-12-03 | Basf Plant Science Company Gmbh | Fungal resistant plants expressing OCP3 |
WO2022043559A2 (en) | 2020-08-31 | 2022-03-03 | Basf Se | Yield improvement |
WO2022263285A1 (en) | 2021-06-14 | 2022-12-22 | Basf Se | Yield improvement by gene combinations |
WO2024126301A1 (en) | 2022-12-14 | 2024-06-20 | BASF Agricultural Solutions Seed US LLC | Broad fungal pathogen resistance in crop plants |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9765356B2 (en) * | 2011-06-27 | 2017-09-19 | Basf Plant Science Company Gmbh | Phacosporacea resistant soybean plants |
CN106701781A (en) * | 2016-12-21 | 2017-05-24 | 东北林业大学 | ERF transcriptional regulation factor gene of hybrid poplar antirust fungi as well as primer and application thereof |
CN112359049B (en) * | 2020-12-10 | 2022-01-28 | 昆明理工大学 | Lilium regale chitinase gene LrCHI2 and application thereof |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1997047183A1 (en) * | 1996-06-12 | 1997-12-18 | Purdue Research Foundation | Genes enhancing disease resistance in plants |
CN101033252A (en) * | 2007-02-06 | 2007-09-12 | 中国农业科学院作物科学研究所 | Plant ERF transcription factor, encode gene and application thereof |
CN101665532A (en) * | 2009-10-12 | 2010-03-10 | 中国农业科学院棉花研究所 | Cotton disease resistance related transcription factor MEREB1 as well as coding gene and application thereof |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9765356B2 (en) * | 2011-06-27 | 2017-09-19 | Basf Plant Science Company Gmbh | Phacosporacea resistant soybean plants |
-
2012
- 2012-06-25 US US14/128,142 patent/US9765356B2/en active Active
- 2012-06-25 WO PCT/IB2012/053193 patent/WO2013001435A1/en active Application Filing
- 2012-06-25 BR BR112013033494-0A patent/BR112013033494B1/en active IP Right Grant
- 2012-06-25 CN CN201280032245.1A patent/CN103620037A/en active Pending
- 2012-06-25 CA CA2838795A patent/CA2838795A1/en not_active Abandoned
- 2012-06-25 EP EP12805174.5A patent/EP2723867A1/en not_active Withdrawn
- 2012-06-25 AU AU2012277381A patent/AU2012277381A1/en not_active Abandoned
- 2012-06-26 AR ARP120102296A patent/AR087160A1/en unknown
-
2017
- 2017-08-30 US US15/691,031 patent/US10696981B2/en active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1997047183A1 (en) * | 1996-06-12 | 1997-12-18 | Purdue Research Foundation | Genes enhancing disease resistance in plants |
CN101033252A (en) * | 2007-02-06 | 2007-09-12 | 中国农业科学院作物科学研究所 | Plant ERF transcription factor, encode gene and application thereof |
CN101665532A (en) * | 2009-10-12 | 2010-03-10 | 中国农业科学院棉花研究所 | Cotton disease resistance related transcription factor MEREB1 as well as coding gene and application thereof |
Non-Patent Citations (2)
Title |
---|
DONG, HONGPING ET AL.: "Studies on methods in cloning and expression quantification of genes that regulate plant disease resistance signal transduction.", JOURNAL OF NANJING AGRICULTURAL UNIVERSITY, vol. 26, no. 4, December 2003 (2003-12-01), pages 30 - 35, XP008169326 * |
MARTA BERROCAL-LOBO ET AL.: "Constitutive expression of ETHYLENE-RESPONSE- FACTOR 1 in Arabidopsis confers resistance to several necrotrophic fungi.", THE PLANT JOURNAL, vol. 29, no. 1, 2002, pages 23 - 32, XP003004905 * |
Cited By (38)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10329579B2 (en) | 2011-12-23 | 2019-06-25 | Basf Plant Science Company Gmbh | Genes to enhance disease resistance in crops |
US9688999B2 (en) | 2012-04-05 | 2017-06-27 | Basf Plant Science Company Gmbh | Fungal resistant plants expressing ACD |
US11447794B2 (en) | 2012-04-05 | 2022-09-20 | Basf Plant Science Company Gmbh | Method of increasing resistance to a fungal pathogen by applying a hydrophobin to a plant |
US10450582B2 (en) | 2012-04-05 | 2019-10-22 | Basf Plant Science Company Gmbh | Fungal resistant plants expressing ACD |
US10344296B2 (en) | 2012-04-05 | 2019-07-09 | Basf Plant Science Company Gmbh | Fungal resistant plants expressing hydrophobin |
US10494643B2 (en) | 2012-04-11 | 2019-12-03 | Basf Plant Science Company Gmbh | Fungal resistant plants expressing OCP3 |
US11180772B2 (en) | 2012-08-09 | 2021-11-23 | Basf Plant Science Company Gmbh | Fungal resistant plants expressing RLK2 |
US10329580B2 (en) | 2012-08-09 | 2019-06-25 | Basf Plant Science Company Gmbh | Fungal resistant plants expressing RLK1 |
US11708584B2 (en) | 2012-08-09 | 2023-07-25 | Basf Plant Science Company Gmbh | Fungal resistant plants expressing RLK2 |
US11142774B2 (en) | 2012-08-09 | 2021-10-12 | Basf Plant Science Company Gmbh | Fungal resistant plants expressing RLK1 |
US9944946B2 (en) | 2012-08-09 | 2018-04-17 | Basf Plant Science Company Gmbh | Fungal resistant plants expressing HCP4 |
US10023875B2 (en) | 2012-08-09 | 2018-07-17 | Basf Plant Science Company Gmbh | Fungal resistant plants expressing HCP5 |
US10066239B2 (en) | 2012-08-09 | 2018-09-04 | Basf Plant Science Company Gmbh | Fungal resistant plants expressing RLK2 |
US11708583B2 (en) | 2012-08-09 | 2023-07-25 | Basf Plant Science Company Gmbh | Fungal resistant plants expressing RLK1 |
US9957522B2 (en) | 2012-11-13 | 2018-05-01 | Basf Plant Science Company Gmbh | Fungal resistant plants expressing CASAR |
CN104981149A (en) * | 2013-01-29 | 2015-10-14 | 巴斯夫植物科学有限公司 | Fungal resistant plants expressing EIN2 |
US10925223B2 (en) | 2013-01-29 | 2021-02-23 | Basf Plant Science Company Gmbh | Fungal resistant plants expressing EIN2 |
CN104994725B (en) * | 2013-01-29 | 2022-07-01 | 巴斯夫植物科学有限公司 | Antifungal plants expressing HCP6 |
CN104955324A (en) * | 2013-01-29 | 2015-09-30 | 巴斯夫植物科学有限公司 | Fungal resistant plants expressing HCP7 |
US10435705B2 (en) | 2013-01-29 | 2019-10-08 | Basf Plant Science Company Gmbh | Fungal resistant plants expressing HCP6 |
WO2014117988A1 (en) * | 2013-01-29 | 2014-08-07 | Basf Plant Science Company Gmbh | Fungal resistant plants expressing hcp7 |
US10462994B2 (en) | 2013-01-29 | 2019-11-05 | Basf Plant Science Company Gmbh | Fungal resistant plants expressing HCP7 |
CN104994725A (en) * | 2013-01-29 | 2015-10-21 | 巴斯夫植物科学有限公司 | Fungal resistant plants expressing hcp6 |
WO2014117990A1 (en) * | 2013-01-29 | 2014-08-07 | Basf Plant Science Company Gmbh | Fungal resistant plants expressing hcp6 |
WO2014118018A1 (en) * | 2013-01-29 | 2014-08-07 | Basf Plant Science Company Gmbh | Fungal resistant plants expressing ein2 |
US10231397B2 (en) | 2013-01-29 | 2019-03-19 | Basf Plant Science Company Gmbh | Fungal resistant plants expressing EIN2 |
US10465204B2 (en) | 2013-03-08 | 2019-11-05 | Basf Plant Science Company Gmbh | Fungal resistant plants expressing MybTF |
EP3263592A1 (en) * | 2013-03-13 | 2018-01-03 | E. I. du Pont de Nemours and Company | Identification of p. pachyrhizi protein effectors and their use in producing asian soybean rust (asr) resistant plants |
US9416368B2 (en) | 2013-03-13 | 2016-08-16 | E I Du Pont De Nemours And Company | Identification of P. pachyrhizi protein effectors and their use in producing Asian soybean rust (ASR) resistant plants |
WO2014165066A3 (en) * | 2013-03-13 | 2014-11-27 | E. I. Dupont De Nemours & Company | Identification of p. pachyrhizi protein effectors and their use in producing asian soybean rust (asr) resistant plants |
WO2019016323A1 (en) * | 2017-07-20 | 2019-01-24 | Rijk Zwaan Zaadteelt En Zaadhandel B.V. | Genetic basis for pythium resistance |
US11516980B2 (en) | 2017-07-20 | 2022-12-06 | Rijk Zwaan Zaadteelt En Zaadhandel B.V. | Genetic basis for Pythium resistance |
CN110891416B (en) * | 2017-07-20 | 2023-07-14 | 瑞克斯旺种苗集团公司 | Genetic basis of Pythium resistance |
CN110891416A (en) * | 2017-07-20 | 2020-03-17 | 瑞克斯旺种苗集团公司 | Genetic basis for Pythium resistance |
WO2022043559A3 (en) * | 2020-08-31 | 2022-05-27 | Basf Se | Plant yield improvement |
WO2022043559A2 (en) | 2020-08-31 | 2022-03-03 | Basf Se | Yield improvement |
WO2022263285A1 (en) | 2021-06-14 | 2022-12-22 | Basf Se | Yield improvement by gene combinations |
WO2024126301A1 (en) | 2022-12-14 | 2024-06-20 | BASF Agricultural Solutions Seed US LLC | Broad fungal pathogen resistance in crop plants |
Also Published As
Publication number | Publication date |
---|---|
BR112013033494A2 (en) | 2018-06-19 |
CN103620037A (en) | 2014-03-05 |
CA2838795A1 (en) | 2013-01-03 |
US9765356B2 (en) | 2017-09-19 |
US10696981B2 (en) | 2020-06-30 |
US20180044696A1 (en) | 2018-02-15 |
AU2012277381A1 (en) | 2014-01-09 |
BR112013033494B1 (en) | 2021-04-27 |
AR087160A1 (en) | 2014-02-26 |
EP2723867A1 (en) | 2014-04-30 |
US20140208460A1 (en) | 2014-07-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US10696981B2 (en) | Phacosporacea resistant soybean plants | |
US10696980B2 (en) | Method of increasing resistance against soybean rust in transgenic plants by ADR-1-gene | |
US10925223B2 (en) | Fungal resistant plants expressing EIN2 | |
US11180772B2 (en) | Fungal resistant plants expressing RLK2 | |
US10450582B2 (en) | Fungal resistant plants expressing ACD | |
US10041088B2 (en) | Fungal resistant plants expressing CASAR | |
US10462994B2 (en) | Fungal resistant plants expressing HCP7 | |
CN104994725B (en) | Antifungal plants expressing HCP6 | |
US10023875B2 (en) | Fungal resistant plants expressing HCP5 | |
US9944946B2 (en) | Fungal resistant plants expressing HCP4 | |
US10465204B2 (en) | Fungal resistant plants expressing MybTF | |
WO2013152917A1 (en) | Fungal resistant plants expressing ocp3 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 12805174 Country of ref document: EP Kind code of ref document: A1 |
|
ENP | Entry into the national phase |
Ref document number: 2838795 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2012805174 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: MX/A/2013/015122 Country of ref document: MX |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
ENP | Entry into the national phase |
Ref document number: 2012277381 Country of ref document: AU Date of ref document: 20120625 Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 14128142 Country of ref document: US |
|
REG | Reference to national code |
Ref country code: BR Ref legal event code: B01A Ref document number: 112013033494 Country of ref document: BR |
|
REG | Reference to national code |
Ref country code: BR Ref legal event code: B01E Ref document number: 112013033494 Country of ref document: BR |
|
ENP | Entry into the national phase |
Ref document number: 112013033494 Country of ref document: BR Kind code of ref document: A2 Effective date: 20131226 |